{
  "directed": true,
  "graph": {
    "annotation_list": {
      "Braak_Stage": [
        "Stage I",
        "Stage II",
        "Stage III",
        "Stage IV",
        "Stage V",
        "Stage VI"
      ],
      "HBP_Disease": [
        "Corticobasal Degeneration",
        "Frontotemporal Lobar Degeneration",
        "Lewy Body Disease, Diffuse"
      ],
      "Method": [
        "Immunohistochemistry",
        "In-vivo two photon calcium imaging",
        "Laser Capture Microdissection",
        "Microarray",
        "NMR Spectroscopy",
        "RT-PCR",
        "Terminal Continuation RNA Amplification",
        "Western Blot"
      ],
      "MouseStrain": [
        "rTg4510"
      ],
      "TauIsoform": [
        "Isoform F (441 aa)"
      ],
      "TauIsoformGradient": [
        "3R-High",
        "3R-Low",
        "3R-Medium",
        "3R-Very High",
        "4R-High",
        "4R-Low",
        "4R-Medium",
        "4R-Very High"
      ]
    },
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "Gender": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "document_metadata": {
      "authors": "Kristian Kolpeja",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved",
      "description": "Tau Biochemistry Section of TauBase",
      "licenses": "CC BY 4.0",
      "name": "Tau Biochemistry",
      "version": "1.2.5"
    },
    "namespace_pattern": {
      "DBSNP": "rs[0-9]+",
      "PUBCHEM": "^\\d+$",
      "TAXONOMY": "^\\d+$",
      "UNIPROT": "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\\.\\d+)?$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/external/hgnc.genefamily-names.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/conso/1646a2ec453bf0a8d75572a4b1672596181a87e9/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/01c9daa61012b37dd0a1bc962521ba51a15b38f1/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
      "PFAM": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns",
      "RGD": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns"
    },
    "namespaces_uncached": [],
    "path": "tau/taubase/tau_biochemistry.bel",
    "pybel_version": "0.13.2"
  },
  "links": [
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "There are six major isoforms in the human brain containing 352–441 amino acid residues, which arise from alternative mRNA splicing of exons 2, 3, and 10 of the Tau gene (46). ",
      "key": "75a4e8b28cdaf51acb41bbca31002e89d2016cbdb7c84334c93dab2600972fbf7fc349581ba50408a5db73148592273cadf60a78e0b67aabc30549c5db40c900",
      "line": 87,
      "relation": "partOf",
      "source": 29,
      "target": 8
    },
    {
      "key": "17d874059d1924ea15913a5f7a69567b2b6767dc31b19deba10e5322f5118fd3a2a83b254c5f80111ef4891814f97427586045947f3a9fb33a6a9a84a995c6e2",
      "relation": "hasVariant",
      "source": 29,
      "target": 30
    },
    {
      "key": "98cdf0df24e7203562c1212c3fd9bd68c567a38e9b5f1b212a8cc7dd36be357b0cc0109470bcd95e46b94c8654f3acd86659eb7097aab3238fc7651533aedf83",
      "relation": "hasVariant",
      "source": 29,
      "target": 31
    },
    {
      "key": "09feedab27d4a99ab8d5084e9d6f7c8c5468fa0f185bbebed0cb8b8e2419c95d75acbd84c524a8d5edb84e07d5a4d5512e62010d5fb7d6bbd9cf7b4dd8a5105b",
      "relation": "hasVariant",
      "source": 29,
      "target": 32
    },
    {
      "key": "43793ebf54ff7fcd180889d30bfe81f6a81eb41d3cda39ce69b5af5166ce724df793ffab060e5d2a4da7585cf390befe79bf8edf3d607461fab821f067a39a09",
      "relation": "hasVariant",
      "source": 29,
      "target": 33
    },
    {
      "key": "ba46eb94f84e66ab301f77a4c69c8b7ad95cfa5b15e3bd3078a236749dc5c8bdb41a659de36476b4445dab7545ba59f44b208590257c290ad91a2d00f4b7d208",
      "relation": "hasVariant",
      "source": 29,
      "target": 34
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "Because tracing with anti-tau antibodies does not distinguish between its isoforms, i.e., three-repeat (3R) and four-repeat (4R) tau, it remains to be clarified how these isoforms are related to the evolution of each lesion and its spread.",
      "key": "948c6e97838b579fc470bf23b6589950a4f73f295e0789223d98f3189621d4db7572743f205a85fa6aac67509c5efb0e360495757ebd10c5b48aa9c2c6b79813",
      "line": 290,
      "relation": "isA",
      "source": 29,
      "target": 23
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "There are six major isoforms in the human brain containing 352–441 amino acid residues, which arise from alternative mRNA splicing of exons 2, 3, and 10 of the Tau gene (46). ",
      "key": "8375bf974bbf1349231c54cfec275ad9cdef3549bbf1824d5e71a1cf163698a4fa2732fdd08f65dca8257428d764d85d020810b94fe43ad4173610e1303a6d73",
      "line": 88,
      "relation": "partOf",
      "source": 28,
      "target": 8
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "Because tracing with anti-tau antibodies does not distinguish between its isoforms, i.e., three-repeat (3R) and four-repeat (4R) tau, it remains to be clarified how these isoforms are related to the evolution of each lesion and its spread.",
      "key": "c8d2a9927dd48e896d6af6ee581a824bbd94ba8161608903dd2ff2f9628d5d233f43056a6e5fa06e65ada6c2867b8271f8a1c64a04d04b1425db569a43c47b05",
      "line": 291,
      "relation": "isA",
      "source": 28,
      "target": 23
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "There are six major isoforms in the human brain containing 352–441 amino acid residues, which arise from alternative mRNA splicing of exons 2, 3, and 10 of the Tau gene (46). ",
      "key": "fd211391a5ecbcacc3e1d2b2e2bc746fb165e6705b10c7b03a9d430d5ac07c6ddfb3d93439c6430ed9baeacfb1e1a664b1fb5f16e63ed22ff41c638725b58d01",
      "line": 89,
      "relation": "partOf",
      "source": 27,
      "target": 8
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "Because tracing with anti-tau antibodies does not distinguish between its isoforms, i.e., three-repeat (3R) and four-repeat (4R) tau, it remains to be clarified how these isoforms are related to the evolution of each lesion and its spread.",
      "key": "a2be8a91f3b1a5567ce69b5b1d77e91d5a910fd852fe6ec3326a6aa69b2297bafc235a95729b7270a77faaf69eb397ff5ccdb44db80df3bf9e9ad625ffcfccb4",
      "line": 292,
      "relation": "isA",
      "source": 27,
      "target": 23
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "There are six major isoforms in the human brain containing 352–441 amino acid residues, which arise from alternative mRNA splicing of exons 2, 3, and 10 of the Tau gene (46). ",
      "key": "b27ac99ccce042d23dd15651ddab88b868763ca7879660989a4b14302bc791d08e7b888bd30a0a50615e33e9b78184ee3d565cad65bca2f73e12943ef3a01aa1",
      "line": 90,
      "relation": "partOf",
      "source": 26,
      "target": 8
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "Because tracing with anti-tau antibodies does not distinguish between its isoforms, i.e., three-repeat (3R) and four-repeat (4R) tau, it remains to be clarified how these isoforms are related to the evolution of each lesion and its spread.",
      "key": "e18af7f1e20f104979e1ef155fdd20ad41cf5827e64ac1b2ccb5d18452cae4e39a48756be2bc834ca7bd60c76891d619217ebe06e32ddada8b0755d60fcfc881",
      "line": 293,
      "relation": "isA",
      "source": 26,
      "target": 22
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "There are six major isoforms in the human brain containing 352–441 amino acid residues, which arise from alternative mRNA splicing of exons 2, 3, and 10 of the Tau gene (46). ",
      "key": "fa5ee2aee3fde8016e18312aff81f24a506addbed6317124bcb3eb70ce698d1df02bb6e241130903a5917d89d966b54de3a5e21e7eaf409d4b3f322920766fce",
      "line": 91,
      "relation": "partOf",
      "source": 25,
      "target": 8
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "Because tracing with anti-tau antibodies does not distinguish between its isoforms, i.e., three-repeat (3R) and four-repeat (4R) tau, it remains to be clarified how these isoforms are related to the evolution of each lesion and its spread.",
      "key": "52ae3992d77ea711e01d8ef225513e2d1bd668ac1f3c03f0f11239356123177e409a0b8c9616f62f034db9f9275face0a824ce6420e8abc50d46d1fb8623a5cf",
      "line": 294,
      "relation": "isA",
      "source": 25,
      "target": 22
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "There are six major isoforms in the human brain containing 352–441 amino acid residues, which arise from alternative mRNA splicing of exons 2, 3, and 10 of the Tau gene (46). ",
      "key": "49c2b848b5e636f04e647e5ec8d2a78186120ea062b085a54136a600967bcd9d3dbed6bbfd316f80b42651f1dcef63f9e966d71deaf872b5791ba698467684c6",
      "line": 92,
      "relation": "partOf",
      "source": 35,
      "target": 8
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The projection domain represents roughly the N-terminal half of the molecule and the assembly domain the C terminal half (114). The C-terminal half of tau contains three or four semi-conserved repeats, a feature shared with other MAPs. Depending on developmentally controlled alternative mRNA splicing, the repeat domain of tau consists of three or four sequences of 31 or 32 residues each: R1 = Q244 − K274, R2 = V275 − S305, R3 = V306 − Q336,R4 = V337 − N368",
      "key": "4f248f6c66c41f7ab0ef4ae14bb7ece24a8105a57c2e1eb7e4ad09947b399c477422b0f6103d7515b507f73f1789bb591c438f4c9495c844d1e8ebaba9aaf69b",
      "line": 101,
      "relation": "partOf",
      "source": 44,
      "target": 39
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The projection domain represents roughly the N-terminal half of the molecule and the assembly domain the C terminal half (114). The C-terminal half of tau contains three or four semi-conserved repeats, a feature shared with other MAPs. Depending on developmentally controlled alternative mRNA splicing, the repeat domain of tau consists of three or four sequences of 31 or 32 residues each: R1 = Q244 − K274, R2 = V275 − S305, R3 = V306 − Q336,R4 = V337 − N368",
      "key": "fd2c4fc8cc8e3bdda6624cd654fcd9739168b40bcbe72fb5ebbf4bc40412c36b68666bc0fdd0ab8fa6d066422bcfc1ec43bb931ea770f392997f3ae1f02a11c6",
      "line": 106,
      "relation": "isA",
      "source": 44,
      "target": 87
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The projection domain represents roughly the N-terminal half of the molecule and the assembly domain the C terminal half (114). The C-terminal half of tau contains three or four semi-conserved repeats, a feature shared with other MAPs. Depending on developmentally controlled alternative mRNA splicing, the repeat domain of tau consists of three or four sequences of 31 or 32 residues each: R1 = Q244 − K274, R2 = V275 − S305, R3 = V306 − Q336,R4 = V337 − N368",
      "key": "4d22e11c21373ba0bdb2c1bfd7eb59347677e04905eb86182d97dc5ade2ab827fb105580707a179d8bce924f16f34fe18729c6dc9b5feadee17cbbd0196445d0",
      "line": 116,
      "relation": "equivalentTo",
      "source": 44,
      "target": 30
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "Because tracing with anti-tau antibodies does not distinguish between its isoforms, i.e., three-repeat (3R) and four-repeat (4R) tau, it remains to be clarified how these isoforms are related to the evolution of each lesion and its spread.",
      "key": "03b20339c8802ad527a10248fee30b062122be1d5d5ba064e4a62693b17edcf8def28cd595c45c450aed9c55d42657ce8a80bb57847fc9e71a507493171dc47d",
      "line": 296,
      "relation": "partOf",
      "source": 44,
      "target": 23
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "Because tracing with anti-tau antibodies does not distinguish between its isoforms, i.e., three-repeat (3R) and four-repeat (4R) tau, it remains to be clarified how these isoforms are related to the evolution of each lesion and its spread.",
      "key": "b073a83292ab1fb2dc4c9f00fdfc1fe43c174d34d59d7f4ea81d8fb686fb33a72e1827b8d615cf5ab6096a6ea30077be9f950f1ad9ecdc29fab1847c02f771bb",
      "line": 301,
      "relation": "partOf",
      "source": 44,
      "target": 22
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The projection domain represents roughly the N-terminal half of the molecule and the assembly domain the C terminal half (114). The C-terminal half of tau contains three or four semi-conserved repeats, a feature shared with other MAPs. Depending on developmentally controlled alternative mRNA splicing, the repeat domain of tau consists of three or four sequences of 31 or 32 residues each: R1 = Q244 − K274, R2 = V275 − S305, R3 = V306 − Q336,R4 = V337 − N368",
      "key": "93d471177c77025bcebf70ce4b5ce6325af828b42494b8c97e0806e724ad7bcbcdac50b61b30f158bc79f98cca33c24bed9e57d01a876306ed7ab39dd6f0f25c",
      "line": 111,
      "relation": "partOf",
      "source": 39,
      "target": 64
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The projection domain represents roughly the N-terminal half of the molecule and the assembly domain the C terminal half (114). The C-terminal half of tau contains three or four semi-conserved repeats, a feature shared with other MAPs. Depending on developmentally controlled alternative mRNA splicing, the repeat domain of tau consists of three or four sequences of 31 or 32 residues each: R1 = Q244 − K274, R2 = V275 − S305, R3 = V306 − Q336,R4 = V337 − N368",
      "key": "2376fe3a0029aeaeed77356f8ea2518afa29ea6658c14cfc1f0576c86c633914e0d3aee1a3bfa28654549fc54a81361ef1a4e0fc5c837692cd4186e60d338417",
      "line": 121,
      "relation": "equivalentTo",
      "source": 39,
      "target": 67
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Tau binds to microtubule through the C-terminal repeat domain and 4R bind more tightly than 3R, while phosphorylation, especially of the repeat domain tends to decrease binding.",
      "key": "3ff7679822c5737e3ea6b3268de81076d4b3bee623c6eeb19bfa534be64117f5b8312039671c3187e5e153b8d8780b7e09e054a60120f87d2492d9758bf0ebb1",
      "line": 127,
      "relation": "increases",
      "source": 39,
      "target": 21
    },
    {
      "annotations": {
        "Method": {
          "NMR Spectroscopy": true
        }
      },
      "citation": {
        "authors": [
          "Fauquant C",
          "Gigant B",
          "Knossow M",
          "Landrieu I",
          "Laprévote O",
          "Lippens G",
          "Redeker V",
          "Verdegem D",
          "Wieruszeski JM"
        ],
        "date": "2011-09-23",
        "first": "Fauquant C",
        "last": "Knossow M",
        "name": "The Journal of biological chemistry",
        "pages": "33358-68",
        "reference": "21757739",
        "title": "Systematic identification of tubulin-interacting fragments of the microtubule-associated protein Tau leads to a highly efficient promoter of microtubule assembly.",
        "type": "PubMed",
        "volume": "286"
      },
      "evidence": "In the projection domain, an N-terminal extension and the first part of a proline-rich domain (PR1) are distinguished. The assembly domain consists of the second part of the proline-rich domain (PR2), three or four MTBRs, and a C-terminal extension with an upstream pseudo repeat R. The MTBRs are divided in repeats (R1 to R4) and inter-repeats (ir12, ir23, and ir34).",
      "key": "ada2acb6042af9ee42ef424dab02506fe58ce73351a6df541d87d438071f9c8c755fb319849fc4e813172fe4b7e9b25acf143298bd5652a12f5453d6d8a348fc",
      "line": 178,
      "relation": "partOf",
      "source": 39,
      "target": 38
    },
    {
      "annotations": {
        "Method": {
          "NMR Spectroscopy": true
        }
      },
      "citation": {
        "authors": [
          "Fauquant C",
          "Gigant B",
          "Knossow M",
          "Landrieu I",
          "Laprévote O",
          "Lippens G",
          "Redeker V",
          "Verdegem D",
          "Wieruszeski JM"
        ],
        "date": "2011-09-23",
        "first": "Fauquant C",
        "last": "Knossow M",
        "name": "The Journal of biological chemistry",
        "pages": "33358-68",
        "reference": "21757739",
        "title": "Systematic identification of tubulin-interacting fragments of the microtubule-associated protein Tau leads to a highly efficient promoter of microtubule assembly.",
        "type": "PubMed",
        "volume": "286"
      },
      "evidence": "In the projection domain, an N-terminal extension and the first part of a proline-rich domain (PR1) are distinguished. The assembly domain consists of the second part of the proline-rich domain (PR2), three or four MTBRs, and a C-terminal extension with an upstream pseudo repeat R. The MTBRs are divided in repeats (R1 to R4) and inter-repeats (ir12, ir23, and ir34).",
      "key": "44a770d3288568c9cfa50600b39fb733878c00a66d2d72c09d51272108b8d55431b709ba0b24252cc88f5731c38372905c3f3c1af4e2d3b12d866da827cb0082",
      "line": 179,
      "relation": "equivalentTo",
      "source": 39,
      "target": 71
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The projection domain represents roughly the N-terminal half of the molecule and the assembly domain the C terminal half (114). The C-terminal half of tau contains three or four semi-conserved repeats, a feature shared with other MAPs. Depending on developmentally controlled alternative mRNA splicing, the repeat domain of tau consists of three or four sequences of 31 or 32 residues each: R1 = Q244 − K274, R2 = V275 − S305, R3 = V306 − Q336,R4 = V337 − N368",
      "key": "9481c50ccd8eb6fc00c49b0af554cc686fb28799e3a54869712410d5254f2674687639ae59caa83a5f72701cd6850b17cd9b991ef3d5faf465c000e8e4916ecf",
      "line": 102,
      "relation": "partOf",
      "source": 45,
      "target": 39
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The projection domain represents roughly the N-terminal half of the molecule and the assembly domain the C terminal half (114). The C-terminal half of tau contains three or four semi-conserved repeats, a feature shared with other MAPs. Depending on developmentally controlled alternative mRNA splicing, the repeat domain of tau consists of three or four sequences of 31 or 32 residues each: R1 = Q244 − K274, R2 = V275 − S305, R3 = V306 − Q336,R4 = V337 − N368",
      "key": "9a22bdc7f38113f7d6630a79de30781f6e2060e767089ecc7116cad57783a37240d6add058b2e8f59c53c0f49d5e2d28d27f5c8f754b632d8205682c4a10feb3",
      "line": 107,
      "relation": "isA",
      "source": 45,
      "target": 87
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The projection domain represents roughly the N-terminal half of the molecule and the assembly domain the C terminal half (114). The C-terminal half of tau contains three or four semi-conserved repeats, a feature shared with other MAPs. Depending on developmentally controlled alternative mRNA splicing, the repeat domain of tau consists of three or four sequences of 31 or 32 residues each: R1 = Q244 − K274, R2 = V275 − S305, R3 = V306 − Q336,R4 = V337 − N368",
      "key": "4d4f277fb6abd06fc63392c8e0502d2c18d4749be37c29e51fb340553939ec2da462a1b499565abffde6aff6964d8c15355ebca75a19b7c9ac5b38bbbc6dfe6f",
      "line": 117,
      "relation": "equivalentTo",
      "source": 45,
      "target": 31
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "Because tracing with anti-tau antibodies does not distinguish between its isoforms, i.e., three-repeat (3R) and four-repeat (4R) tau, it remains to be clarified how these isoforms are related to the evolution of each lesion and its spread.",
      "key": "acbda68c23478ee2b6150affb6544457fd0acc0bc3e1a5e5b461ea60909d012cfd358c053fad1f5bf573ff020916f8962a467fd36be6ad472fb73c7eb6afbd3c",
      "line": 297,
      "relation": "partOf",
      "source": 45,
      "target": 23
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "Because tracing with anti-tau antibodies does not distinguish between its isoforms, i.e., three-repeat (3R) and four-repeat (4R) tau, it remains to be clarified how these isoforms are related to the evolution of each lesion and its spread.",
      "key": "75e8563abf02a681810a75c250ded687ad7e375d6d3069ab9f6f83b423d5627f9ef886aa27d3527efa39dab858b0cd67a195d3adbac1878d733ec0e401707374",
      "line": 302,
      "relation": "partOf",
      "source": 45,
      "target": 22
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The projection domain represents roughly the N-terminal half of the molecule and the assembly domain the C terminal half (114). The C-terminal half of tau contains three or four semi-conserved repeats, a feature shared with other MAPs. Depending on developmentally controlled alternative mRNA splicing, the repeat domain of tau consists of three or four sequences of 31 or 32 residues each: R1 = Q244 − K274, R2 = V275 − S305, R3 = V306 − Q336,R4 = V337 − N368",
      "key": "079b84037fe824936dfbecafe1a751fac832ea7aa10f1d6dad23f4384699884c7ca9e8e71f4008b582887f6322afb8b369b823ba9161f1fdeb0391a73e1221af",
      "line": 103,
      "relation": "partOf",
      "source": 46,
      "target": 39
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The projection domain represents roughly the N-terminal half of the molecule and the assembly domain the C terminal half (114). The C-terminal half of tau contains three or four semi-conserved repeats, a feature shared with other MAPs. Depending on developmentally controlled alternative mRNA splicing, the repeat domain of tau consists of three or four sequences of 31 or 32 residues each: R1 = Q244 − K274, R2 = V275 − S305, R3 = V306 − Q336,R4 = V337 − N368",
      "key": "edb9918d27df1feb0c787843110016bd9dd63fae0e3554ba0169774c00b1858e6a5ac5b597ee0cf1c06d9443cbb96f4ce7b13a5a2ed588d54a6d107f9e3fecd8",
      "line": 108,
      "relation": "isA",
      "source": 46,
      "target": 87
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The projection domain represents roughly the N-terminal half of the molecule and the assembly domain the C terminal half (114). The C-terminal half of tau contains three or four semi-conserved repeats, a feature shared with other MAPs. Depending on developmentally controlled alternative mRNA splicing, the repeat domain of tau consists of three or four sequences of 31 or 32 residues each: R1 = Q244 − K274, R2 = V275 − S305, R3 = V306 − Q336,R4 = V337 − N368",
      "key": "8c5b44fad98de5aa6175a4146e4f54ec9d735e678344fd5d2726ca88a234dde213ff80c061a78d9187114297f247e2ecda21140e5ba5a259d1e4024d85d0ac8e",
      "line": 118,
      "relation": "equivalentTo",
      "source": 46,
      "target": 32
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "Because tracing with anti-tau antibodies does not distinguish between its isoforms, i.e., three-repeat (3R) and four-repeat (4R) tau, it remains to be clarified how these isoforms are related to the evolution of each lesion and its spread.",
      "key": "bbf3d06178a22b82b70e5d761dbb22fbb322b48cf3a6b146711e9d34ad192048827fb19218526ed3099f30c68f172f78815a99ac14029d5c54348d662f549469",
      "line": 298,
      "relation": "partOf",
      "source": 46,
      "target": 23
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "Because tracing with anti-tau antibodies does not distinguish between its isoforms, i.e., three-repeat (3R) and four-repeat (4R) tau, it remains to be clarified how these isoforms are related to the evolution of each lesion and its spread.",
      "key": "7cc4861ad0e279b2e1ce4a39f71bc083c59615d10109231f6df0a7e5f350268d478baad22324f9c6030675ebde412b6e700e01f02477c1fb3a356173e78ad75e",
      "line": 303,
      "relation": "partOf",
      "source": 46,
      "target": 22
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The projection domain represents roughly the N-terminal half of the molecule and the assembly domain the C terminal half (114). The C-terminal half of tau contains three or four semi-conserved repeats, a feature shared with other MAPs. Depending on developmentally controlled alternative mRNA splicing, the repeat domain of tau consists of three or four sequences of 31 or 32 residues each: R1 = Q244 − K274, R2 = V275 − S305, R3 = V306 − Q336,R4 = V337 − N368",
      "key": "ca934236e08c0e9f8915abfb1a309f690fcac18f1db37f3adac5a4ace90b6094a97dddff2c5c478c3a42928d35bbd0dcdee547f15257e5ce758899d0b716f917",
      "line": 104,
      "relation": "partOf",
      "source": 47,
      "target": 39
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The projection domain represents roughly the N-terminal half of the molecule and the assembly domain the C terminal half (114). The C-terminal half of tau contains three or four semi-conserved repeats, a feature shared with other MAPs. Depending on developmentally controlled alternative mRNA splicing, the repeat domain of tau consists of three or four sequences of 31 or 32 residues each: R1 = Q244 − K274, R2 = V275 − S305, R3 = V306 − Q336,R4 = V337 − N368",
      "key": "4754d57100310f74e075723a9a1dcbca922aeaa9f011fb1fd592aa1ec2451a87de13619fcb9fa89eb1ce1555db75338c0cc37b10a6d8ced59327903e4d23c1e6",
      "line": 109,
      "relation": "isA",
      "source": 47,
      "target": 87
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The projection domain represents roughly the N-terminal half of the molecule and the assembly domain the C terminal half (114). The C-terminal half of tau contains three or four semi-conserved repeats, a feature shared with other MAPs. Depending on developmentally controlled alternative mRNA splicing, the repeat domain of tau consists of three or four sequences of 31 or 32 residues each: R1 = Q244 − K274, R2 = V275 − S305, R3 = V306 − Q336,R4 = V337 − N368",
      "key": "31f5c55bf58da6513c3fd617c75eb83c252910b73c3fd88e4e09be3e45f787da7ec5947cd3465ab69c4aaa4293d7b51c91d30c83753fcc5e2b868c0c1850898c",
      "line": 119,
      "relation": "equivalentTo",
      "source": 47,
      "target": 33
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Tau binds to microtubule through the C-terminal repeat domain and 4R bind more tightly than 3R, while phosphorylation, especially of the repeat domain tends to decrease binding.",
      "key": "9eb782516f3f971732f67d27caefbcd30283b6f546c8e69df23854aea8165df2cdbdcd853a80e3dea9a0b382d60bf56a0065a09f529f1102cf1078d7379def74",
      "line": 128,
      "relation": "directlyIncreases",
      "source": 47,
      "target": 21
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "Because tracing with anti-tau antibodies does not distinguish between its isoforms, i.e., three-repeat (3R) and four-repeat (4R) tau, it remains to be clarified how these isoforms are related to the evolution of each lesion and its spread.",
      "key": "d83ac872e3efd9b83639a2fc91901c17658f4a718f71919b5d1b80f5adebc0a7de9c6060d0cb9de3a825a49710d2b3d76dd3ae17424a9a7bb8c92cd10ea15a26",
      "line": 299,
      "relation": "partOf",
      "source": 47,
      "target": 23
    },
    {
      "key": "a6d6fb9ef3798fa36b697e0fabd26c6ffe5a178cd6dda1d4f094eb6de9b6c367fd61775dc8301d8d43fc8fb92975a1a80a4963523b3c14347007eb28e9800417",
      "relation": "hasVariant",
      "source": 87,
      "target": 88
    },
    {
      "key": "9c623c3df0e66fdd0c6582b64a7e9a4562622bac6195d4a4eca5806f444fb2809fef15f8c829ee01c9aa59e0ed74e056c539f0e9019d699330096fc908fa0aec",
      "relation": "hasVariant",
      "source": 64,
      "target": 67
    },
    {
      "key": "98cacd1f8e5a410bba8c9d8ce2dcc279d647ca6059c19fceab0967064d2814bf8ab7ec55f660c89c2a0596c22fb3e667da3ac80d2e407d870954d0c84dfbb123",
      "relation": "hasVariant",
      "source": 64,
      "target": 70
    },
    {
      "key": "9cfb692e3b39903e05776d10e5ec184405b65b7ee2afbee7a958ac60be2e0a8de0d684efe5a7fcc4198d4d76591b906798952e7cda8584eb982d9758803184ed",
      "relation": "hasVariant",
      "source": 64,
      "target": 79
    },
    {
      "key": "f331474061d8420a9d0b22a9a209adeca0b96c80867792cb1c63830cc912c379a03f93fa521f0b83be162a4d1dd520b68c8d8819746325caef389ec2dccb2f34",
      "relation": "hasVariant",
      "source": 64,
      "target": 80
    },
    {
      "key": "7c4dab41f0b789fe1a52f61758835723c3b320276f1f4dd19c15f5910c60497a112c4ec2b291ad3da3ffec9bbc530290dd67b167ac4d3ad55e2338982297e705",
      "relation": "hasVariant",
      "source": 64,
      "target": 75
    },
    {
      "key": "a589c91b7da07245f713a8f9a53701e0008f348024f3b4d7269a3669aa6d8aed7ae4b796af132d744cc9019d6ca8a5fbbe1efad97628a39edf287178d99d12f6",
      "relation": "hasVariant",
      "source": 64,
      "target": 76
    },
    {
      "key": "c28131e97f8ddda4cb5d66338c512fa72d213478d3fb903b8c56be8fa837ddff3d924706e0f313af666e52f58ab0a35cc9e27bbc842535cf78fc089b80c6649f",
      "relation": "hasVariant",
      "source": 64,
      "target": 77
    },
    {
      "key": "1ea70b1fdc71c02106277625f2caa4a966e913c03fe8ad751981023e6b74cc994370be7baa25ecf05138e10d08c4f2af7320c3a733cae82b6b055734105d1821",
      "relation": "hasVariant",
      "source": 64,
      "target": 78
    },
    {
      "key": "7e2720882d6fa374e003f55619af6acd72fd0b6b0e056fde3d6279807f12e1a267d65521562730f5dba91f947c117b5e137ea104b51b15316054d30a3af35372",
      "relation": "hasVariant",
      "source": 64,
      "target": 74
    },
    {
      "key": "46c8afac5f5d4554fec3e3b4a7b58b76344bdd35a5aa06263bfd790effcb02310af16774fded811be41437afa0f045f9bfdabbbcf1f742aa502860f1eb0f6888",
      "relation": "hasVariant",
      "source": 64,
      "target": 68
    },
    {
      "key": "9806e26700982b2f226e0278e37fd45227ada978d5b3dd5a6f2f52d220b3aa15c2ccec348267fdca2d3d55b92c5d2b573610f965339eaf3ccb41a48fd9887281",
      "relation": "hasVariant",
      "source": 64,
      "target": 71
    },
    {
      "key": "4d2febbee876191e582c25fcd400ae5f90ed0953a6751a2982ab4132839602d4ef8e071d22710e36719e5aa81ada72300f6885c0cf65aa3633319e78f6d3bc4e",
      "relation": "hasVariant",
      "source": 64,
      "target": 72
    },
    {
      "key": "727b67b6d158e0ea385c7e5a21474263136afb21d7eb972b953ace5fab80586ada45684a868726b0f540be035fbfe134026d9ff207c4a3b317c8c4f233cea037",
      "relation": "hasVariant",
      "source": 64,
      "target": 66
    },
    {
      "key": "95ebee6e8f2c33db2bff107572cbdc36bd02875f52be3fe2fbe823868e320418bf77c4bfcc3da61f967ee7f3c752182de0b38c6304d6c2bdcf62f5b57e15aa14",
      "relation": "hasVariant",
      "source": 64,
      "target": 65
    },
    {
      "key": "20ed4f6da453c94c7d03810968d1fce7f215790e389e4539d75f1a971f355922cd2b7342679e7523a33f67ba791daa51e5e4f25fff5286382a03b422da43642e",
      "relation": "hasVariant",
      "source": 64,
      "target": 69
    },
    {
      "key": "c4e71f1866eab20795e7e1d4b54fe09effb8b376e41712f8a130fe5192e07d83b0749cc2e2297b62cbea4bb7b1033909ea6d6423fa06166cb07543cee4249d48",
      "relation": "hasVariant",
      "source": 64,
      "target": 73
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The projection domain represents roughly the N-terminal half of the molecule and the assembly domain the C terminal half (114). The C-terminal half of tau contains three or four semi-conserved repeats, a feature shared with other MAPs. Depending on developmentally controlled alternative mRNA splicing, the repeat domain of tau consists of three or four sequences of 31 or 32 residues each: R1 = Q244 − K274, R2 = V275 − S305, R3 = V306 − Q336,R4 = V337 − N368",
      "key": "8babb3c54a7f20ad455df6e9f38cbfcaf880e2b6652a567232559b925015c29d10491810271057fd49fc96d75e1695339eae9c32acf940d5d12a0ae23d942766",
      "line": 112,
      "relation": "partOf",
      "source": 40,
      "target": 64
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The projection domain represents roughly the N-terminal half of the molecule and the assembly domain the C terminal half (114). The C-terminal half of tau contains three or four semi-conserved repeats, a feature shared with other MAPs. Depending on developmentally controlled alternative mRNA splicing, the repeat domain of tau consists of three or four sequences of 31 or 32 residues each: R1 = Q244 − K274, R2 = V275 − S305, R3 = V306 − Q336,R4 = V337 − N368",
      "key": "e2b430c1ff0936b64ec29d1a38cdf7d8381014670d4e44befc2582c725d63f1922fb5b159d4b7d74bc0d8491e8640018056288cd465cc6811703d4d2866b856b",
      "line": 113,
      "relation": "equivalentTo",
      "source": 40,
      "target": 86
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The projection domain represents roughly the N-terminal half of the molecule and the assembly domain the C terminal half (114). The C-terminal half of tau contains three or four semi-conserved repeats, a feature shared with other MAPs. Depending on developmentally controlled alternative mRNA splicing, the repeat domain of tau consists of three or four sequences of 31 or 32 residues each: R1 = Q244 − K274, R2 = V275 − S305, R3 = V306 − Q336,R4 = V337 − N368",
      "key": "b1f2ce88899f51d89b67e89ab472248c1e683768b6158910d0abc77f80ea3ef878e3d43a6950d19751c5a87d1bdafaf604d027da95eb09b440978524aa5c1842",
      "line": 122,
      "relation": "equivalentTo",
      "source": 40,
      "target": 70
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The projection domain represents roughly the N-terminal half of the molecule and the assembly domain the C terminal half (114). The C-terminal half of tau contains three or four semi-conserved repeats, a feature shared with other MAPs. Depending on developmentally controlled alternative mRNA splicing, the repeat domain of tau consists of three or four sequences of 31 or 32 residues each: R1 = Q244 − K274, R2 = V275 − S305, R3 = V306 − Q336,R4 = V337 − N368",
      "key": "7c63ce001f3a1754da0bf2feb268984bc1b60806385f77005dc2a15d907bfa589b9c2a7522016b529deb9562d0d3c78fe80aca62e8aa9e0b4a5aff44a264df4a",
      "line": 113,
      "relation": "equivalentTo",
      "source": 86,
      "target": 40
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The projection domain represents roughly the N-terminal half of the molecule and the assembly domain the C terminal half (114). The C-terminal half of tau contains three or four semi-conserved repeats, a feature shared with other MAPs. Depending on developmentally controlled alternative mRNA splicing, the repeat domain of tau consists of three or four sequences of 31 or 32 residues each: R1 = Q244 − K274, R2 = V275 − S305, R3 = V306 − Q336,R4 = V337 − N368",
      "key": "7c8faf130bef09c97448186d76117cfc35d43807c8928beeb8c565354f4636738d66a2140ec74464798293765a374e101f18ff6290cef3a7a2a806f53f089438",
      "line": 116,
      "relation": "equivalentTo",
      "source": 30,
      "target": 44
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The projection domain represents roughly the N-terminal half of the molecule and the assembly domain the C terminal half (114). The C-terminal half of tau contains three or four semi-conserved repeats, a feature shared with other MAPs. Depending on developmentally controlled alternative mRNA splicing, the repeat domain of tau consists of three or four sequences of 31 or 32 residues each: R1 = Q244 − K274, R2 = V275 − S305, R3 = V306 − Q336,R4 = V337 − N368",
      "key": "725be59e305df87482d1beb4a68012b33273b52b029cb6f8403531a5055cb8ec79fe1aefe2a2cdfffa925a63dab858b9613640a4a34fd49e0aa4d5e5cfab4463",
      "line": 117,
      "relation": "equivalentTo",
      "source": 31,
      "target": 45
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The projection domain represents roughly the N-terminal half of the molecule and the assembly domain the C terminal half (114). The C-terminal half of tau contains three or four semi-conserved repeats, a feature shared with other MAPs. Depending on developmentally controlled alternative mRNA splicing, the repeat domain of tau consists of three or four sequences of 31 or 32 residues each: R1 = Q244 − K274, R2 = V275 − S305, R3 = V306 − Q336,R4 = V337 − N368",
      "key": "e2468d9d4a38601660f3b4eb4c8af9641fad14ba2f507110d1a2ee2dc87614c3062c52df97b8b8bcf3c91f1cdcd78a9d0a33e4785ce7bdf00699b7566513611f",
      "line": 118,
      "relation": "equivalentTo",
      "source": 32,
      "target": 46
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The projection domain represents roughly the N-terminal half of the molecule and the assembly domain the C terminal half (114). The C-terminal half of tau contains three or four semi-conserved repeats, a feature shared with other MAPs. Depending on developmentally controlled alternative mRNA splicing, the repeat domain of tau consists of three or four sequences of 31 or 32 residues each: R1 = Q244 − K274, R2 = V275 − S305, R3 = V306 − Q336,R4 = V337 − N368",
      "key": "bc3d3f219866990cee8bcdb209e23ecd211d8f6ee611b76167ae306f47d1be6131fc2bfa1deb5b8f7e25995dd0bafa1743e9081468feed130dd4935a5c791120",
      "line": 119,
      "relation": "equivalentTo",
      "source": 33,
      "target": 47
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The projection domain represents roughly the N-terminal half of the molecule and the assembly domain the C terminal half (114). The C-terminal half of tau contains three or four semi-conserved repeats, a feature shared with other MAPs. Depending on developmentally controlled alternative mRNA splicing, the repeat domain of tau consists of three or four sequences of 31 or 32 residues each: R1 = Q244 − K274, R2 = V275 − S305, R3 = V306 − Q336,R4 = V337 − N368",
      "key": "4d23ba62def9b7cdaaf7f141b17e7623c6135312a1eb7a4ae3ea15667ef9bcaddc9d9d9c4123634691e1931bc0a85706b51f22b4a848d151db69457469858b73",
      "line": 121,
      "relation": "equivalentTo",
      "source": 67,
      "target": 39
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The projection domain represents roughly the N-terminal half of the molecule and the assembly domain the C terminal half (114). The C-terminal half of tau contains three or four semi-conserved repeats, a feature shared with other MAPs. Depending on developmentally controlled alternative mRNA splicing, the repeat domain of tau consists of three or four sequences of 31 or 32 residues each: R1 = Q244 − K274, R2 = V275 − S305, R3 = V306 − Q336,R4 = V337 − N368",
      "key": "ba8fac4f6bcfc5dbc2c960154b6f315ebaf9aee2bc7532f9bfb1eeff8f5e9e14da883ebd3e5d3eafe31f28617dccf8d4a703c2e660daaf67826abe43e7220895",
      "line": 122,
      "relation": "equivalentTo",
      "source": 70,
      "target": 40
    },
    {
      "key": "82e95e1281a6fd85d76120f3b090313093acd7911f02dcde6dc4100665aa6de120b4e1d765aa1437092fbde2987951b431d1758b12f58222dde1168148f34eb4",
      "relation": "hasComponent",
      "source": 21,
      "target": 64
    },
    {
      "key": "0b141c8f8d20b598b9f5bd64c38cb71ae3e2b9fe2002e0aa72bb6223ccb557a84a34c3843e92ef413bca9f5dbfaea2066f5075a11631329fc06257ce1e7b43ca",
      "relation": "hasComponent",
      "source": 21,
      "target": 85
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Tau binds to microtubule through the C-terminal repeat domain and 4R bind more tightly than 3R, while phosphorylation, especially of the repeat domain tends to decrease binding.",
      "key": "69118dd1f8ac6d8a87c096b6c8682bde54d84c64c96f0eed0f194feaa195ea300b8e2337f607194ea60df616e676af5644e91cbbc2134dda8f537456cdcb9435",
      "line": 129,
      "relation": "decreases",
      "source": 88,
      "target": 21
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Two hexapeptide motifs at the beginning of R2 and R3 promote paired helical filament (PHF) aggregation by inducing β-structure.",
      "key": "29c36dd69c9fcaf030426f0f7e418024de64bb0dfb4f18a350dcb1c253d8c70831326393c90c46527de46744eb9bf17d3b851303afc8a780cc3392ae1e5f3e83",
      "line": 133,
      "relation": "partOf",
      "source": 36,
      "target": 45
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Two hexapeptide motifs at the beginning of R2 and R3 promote paired helical filament (PHF) aggregation by inducing β-structure.",
      "key": "0ef3c10749bef1b5128174223026fc1a12f127a68fb3c3a1aebd6a16347723d18b31a0702d8cfdf1c1080a135ec05cc4ef82c1f4591d5053916bfcf6a58439bb",
      "line": 135,
      "relation": "increases",
      "source": 36,
      "target": 12
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Two hexapeptide motifs at the beginning of R2 and R3 promote paired helical filament (PHF) aggregation by inducing β-structure.",
      "key": "c65a643a9923c22da3172ed8c5064d88ec4229be68ecd8cdf148c68ae9d4ebe755db21f5ae19353efb1b06f53d4ebc4fc39c2b813d011d24de6159b249521333",
      "line": 134,
      "relation": "partOf",
      "source": 37,
      "target": 46
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Two hexapeptide motifs at the beginning of R2 and R3 promote paired helical filament (PHF) aggregation by inducing β-structure.",
      "key": "2897bbe03bfb7852ce5bc8a9ee57ee56cb47598a93326afeaed53fe647dcbe56dbbde80f62bc8814a1f764a2e9d08e0ab7d98ba5cc3ea1530fc9561cb5e965c1",
      "line": 136,
      "relation": "increases",
      "source": 37,
      "target": 12
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Tyrosine kinases target Y18 [fyn, (79)] and Y394 [abl, (31)].",
      "key": "b55925102d00b69de2fe07e1c9951c2231689d06db837ef7f130e1c29a65ff36d4f355e22b003e4a9152ca1608180a5607aa4304f650504ba512abfe7e7b110a",
      "line": 140,
      "relation": "increases",
      "source": 60,
      "target": 79
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Tyrosine kinases target Y18 [fyn, (79)] and Y394 [abl, (31)].",
      "key": "0e556a6dbe2bc51c8928a0f5f622d5f275ca13aed29c05aaba9e10d474f490f5df1b3b70dfad92fdb2b9097da92a50db4e8faf2afe31a786c571a87cce9e8a9b",
      "line": 141,
      "relation": "increases",
      "source": 52,
      "target": 80
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The lysine-isoleucine-glycineserine motif (KIGS) or lysine-cysteineglycine-serine motif (KCGS) motifs in the repeat domain (S262, S293, S324, S356) can be phosphorylated by MARK, PKA, SAD kinases, CaMKII and p70S6K, which strongly reduces the tau microtubule interactions (36, 74, 96), [note that phosphorylation at these sites also inhibits tau aggregation, illustrating an analogous role for the repeat domain in the physiological and pathological functions of tau (106)].",
      "key": "3a39f31a36b0927d79651fe48a2f36987123aae2655d2a06c1a38eb6ee24912c0c6aa1583ef52fc3bf4067ec0a17fc4075281b1e2f1526157b465a9596968624",
      "line": 148,
      "relation": "decreases",
      "source": 75,
      "target": 21
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The lysine-isoleucine-glycineserine motif (KIGS) or lysine-cysteineglycine-serine motif (KCGS) motifs in the repeat domain (S262, S293, S324, S356) can be phosphorylated by MARK, PKA, SAD kinases, CaMKII and p70S6K, which strongly reduces the tau microtubule interactions (36, 74, 96), [note that phosphorylation at these sites also inhibits tau aggregation, illustrating an analogous role for the repeat domain in the physiological and pathological functions of tau (106)].",
      "key": "e9aa4296fecc1811012c842972e0f75097d0f9b36cf2cbdf945991826fe51054d85530267bc7e46bcdeefcc0b8e1c5af1d49659e0ed9a97f13c4dcf588304f82",
      "line": 153,
      "relation": "decreases",
      "source": 75,
      "target": 12
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The lysine-isoleucine-glycineserine motif (KIGS) or lysine-cysteineglycine-serine motif (KCGS) motifs in the repeat domain (S262, S293, S324, S356) can be phosphorylated by MARK, PKA, SAD kinases, CaMKII and p70S6K, which strongly reduces the tau microtubule interactions (36, 74, 96), [note that phosphorylation at these sites also inhibits tau aggregation, illustrating an analogous role for the repeat domain in the physiological and pathological functions of tau (106)].",
      "key": "1fd355929513fbca23e2c739fe0afb5aa23491456a693f157b7c732999de36ffa614878a5c9ada731056fad264150824f36ef1cac637a758c71578fc19b0ae70",
      "line": 149,
      "relation": "decreases",
      "source": 76,
      "target": 21
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The lysine-isoleucine-glycineserine motif (KIGS) or lysine-cysteineglycine-serine motif (KCGS) motifs in the repeat domain (S262, S293, S324, S356) can be phosphorylated by MARK, PKA, SAD kinases, CaMKII and p70S6K, which strongly reduces the tau microtubule interactions (36, 74, 96), [note that phosphorylation at these sites also inhibits tau aggregation, illustrating an analogous role for the repeat domain in the physiological and pathological functions of tau (106)].",
      "key": "e4ebbd16d908fe96238827d4d6182a5eac7f261ee88c25fe805928b2309788e9d63924657a97233610fbf305b508d6da4866049bf1b6a69db6c6f0d80406c045",
      "line": 154,
      "relation": "decreases",
      "source": 76,
      "target": 12
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The lysine-isoleucine-glycineserine motif (KIGS) or lysine-cysteineglycine-serine motif (KCGS) motifs in the repeat domain (S262, S293, S324, S356) can be phosphorylated by MARK, PKA, SAD kinases, CaMKII and p70S6K, which strongly reduces the tau microtubule interactions (36, 74, 96), [note that phosphorylation at these sites also inhibits tau aggregation, illustrating an analogous role for the repeat domain in the physiological and pathological functions of tau (106)].",
      "key": "c6d67d7b810b8322272c6ed94281e0bfb8bc946e232bda191f146ee433c669f3c13a0c8a6dbe9d6d5fb789bd7448c38029e89beb6b7f505a342eb4a43d95a7b4",
      "line": 150,
      "relation": "decreases",
      "source": 77,
      "target": 21
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The lysine-isoleucine-glycineserine motif (KIGS) or lysine-cysteineglycine-serine motif (KCGS) motifs in the repeat domain (S262, S293, S324, S356) can be phosphorylated by MARK, PKA, SAD kinases, CaMKII and p70S6K, which strongly reduces the tau microtubule interactions (36, 74, 96), [note that phosphorylation at these sites also inhibits tau aggregation, illustrating an analogous role for the repeat domain in the physiological and pathological functions of tau (106)].",
      "key": "981d6e255cf09ec922b13ff31d342018761e0d8d31edfacfd1aa48487ad5f0fa279cf6e3d312e6af4654bc53c5f7572bea72a7ed30b09d440e1330437ebbff68",
      "line": 155,
      "relation": "decreases",
      "source": 77,
      "target": 12
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The lysine-isoleucine-glycineserine motif (KIGS) or lysine-cysteineglycine-serine motif (KCGS) motifs in the repeat domain (S262, S293, S324, S356) can be phosphorylated by MARK, PKA, SAD kinases, CaMKII and p70S6K, which strongly reduces the tau microtubule interactions (36, 74, 96), [note that phosphorylation at these sites also inhibits tau aggregation, illustrating an analogous role for the repeat domain in the physiological and pathological functions of tau (106)].",
      "key": "4e9841fc60f55fa5ecd39426a5f409444ed2974003d6b3da2eb062a360fa09e2257c6bdd1e8f70b2c55706664df00b1d66450e8179f00ed18d6dd5c3f7fa3cbb",
      "line": 151,
      "relation": "decreases",
      "source": 78,
      "target": 21
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The lysine-isoleucine-glycineserine motif (KIGS) or lysine-cysteineglycine-serine motif (KCGS) motifs in the repeat domain (S262, S293, S324, S356) can be phosphorylated by MARK, PKA, SAD kinases, CaMKII and p70S6K, which strongly reduces the tau microtubule interactions (36, 74, 96), [note that phosphorylation at these sites also inhibits tau aggregation, illustrating an analogous role for the repeat domain in the physiological and pathological functions of tau (106)].",
      "key": "01364aef29fafc48a9b88808551dd3b1132e35f01983c0c696bb59e83b97a8f5888954602ed692e81d6bbea746a7d3efb74beb4c4176f4aebbe2f74d316896bc",
      "line": 156,
      "relation": "decreases",
      "source": 78,
      "target": 12
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "A further potent detaching site is phosphoS214, which can be phosphorylated by PKA and other kinases of the AGC group (PKA/PKG/PKC group of protein kinases), and is up-regulated during mitosis (16, 63). Tau contains one or two cysteines in the repeat domain (C291 in R2, present in 4R isoforms, and C322 in R3), which can be engaged in intra- or intermolecular cross-linking affecting conformation, dimerization and aggregation (108).",
      "key": "612f58bf95a4214c9e736f0c1ba9929fc236de4d4d77606393d90caabd3ff5c3e760e3ede980f1aa01b3133cb479718d012cdfa202998baec8c1a5a74108307e",
      "line": 162,
      "relation": "increases",
      "source": 49,
      "target": 74
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "A further potent detaching site is phosphoS214, which can be phosphorylated by PKA and other kinases of the AGC group (PKA/PKG/PKC group of protein kinases), and is up-regulated during mitosis (16, 63). Tau contains one or two cysteines in the repeat domain (C291 in R2, present in 4R isoforms, and C322 in R3), which can be engaged in intra- or intermolecular cross-linking affecting conformation, dimerization and aggregation (108).",
      "key": "0734383837ae4fe3be8773345837b63d7c68e6b45b1b7f986aaba96576b95a1ebf8bcade05aa7e798a77a0bfa4196559bcb5ecf6c7238f053e763310181d4a93",
      "line": 163,
      "relation": "increases",
      "source": 50,
      "target": 74
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "A further potent detaching site is phosphoS214, which can be phosphorylated by PKA and other kinases of the AGC group (PKA/PKG/PKC group of protein kinases), and is up-regulated during mitosis (16, 63). Tau contains one or two cysteines in the repeat domain (C291 in R2, present in 4R isoforms, and C322 in R3), which can be engaged in intra- or intermolecular cross-linking affecting conformation, dimerization and aggregation (108).",
      "key": "e6f6a3f19b32dd67ceef5c93793f11f1884db5c721334256efa533d859fd1945fb2bfce59652cd30a755f68f09d2c68933110be3d16fa04c6f7b4e4aac057591",
      "line": 164,
      "relation": "increases",
      "source": 51,
      "target": 74
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Mandelkow E",
          "Mandelkow EM",
          "von Bergen M"
        ],
        "date": "2007-01-01",
        "first": "Mandelkow E",
        "last": "Mandelkow EM",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "83-90",
        "reference": "17493042",
        "title": "Structural principles of tau and the paired helical filaments of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "A further potent detaching site is phosphoS214, which can be phosphorylated by PKA and other kinases of the AGC group (PKA/PKG/PKC group of protein kinases), and is up-regulated during mitosis (16, 63). Tau contains one or two cysteines in the repeat domain (C291 in R2, present in 4R isoforms, and C322 in R3), which can be engaged in intra- or intermolecular cross-linking affecting conformation, dimerization and aggregation (108).",
      "key": "aef4ce5e8e184e720d508f62da3d7c9394a5d88d4fad4dc4423784d8cd98ac1118bb9360732904c822d3484424218e46996fd3f03de40d8150536acac7ca91b8",
      "line": 165,
      "relation": "increases",
      "source": 13,
      "target": 74
    },
    {
      "annotations": {
        "Method": {
          "NMR Spectroscopy": true
        }
      },
      "citation": {
        "authors": [
          "Fauquant C",
          "Gigant B",
          "Knossow M",
          "Landrieu I",
          "Laprévote O",
          "Lippens G",
          "Redeker V",
          "Verdegem D",
          "Wieruszeski JM"
        ],
        "date": "2011-09-23",
        "first": "Fauquant C",
        "last": "Knossow M",
        "name": "The Journal of biological chemistry",
        "pages": "33358-68",
        "reference": "21757739",
        "title": "Systematic identification of tubulin-interacting fragments of the microtubule-associated protein Tau leads to a highly efficient promoter of microtubule assembly.",
        "type": "PubMed",
        "volume": "286"
      },
      "evidence": "In the projection domain, an N-terminal extension and the first part of a proline-rich domain (PR1) are distinguished. The assembly domain consists of the second part of the proline-rich domain (PR2), three or four MTBRs, and a C-terminal extension with an upstream pseudo repeat R. The MTBRs are divided in repeats (R1 to R4) and inter-repeats (ir12, ir23, and ir34).",
      "key": "d2610ad21208292863c01fcbf6e2e64634b01862e240fe046517eb1c7f23c2efa62c85313d83c383976dfeb95855840fa79f5624b2b7394707ba18ecb1011c1e",
      "line": 177,
      "relation": "equivalentTo",
      "source": 38,
      "target": 68
    },
    {
      "annotations": {
        "Method": {
          "NMR Spectroscopy": true
        }
      },
      "citation": {
        "authors": [
          "Fauquant C",
          "Gigant B",
          "Knossow M",
          "Landrieu I",
          "Laprévote O",
          "Lippens G",
          "Redeker V",
          "Verdegem D",
          "Wieruszeski JM"
        ],
        "date": "2011-09-23",
        "first": "Fauquant C",
        "last": "Knossow M",
        "name": "The Journal of biological chemistry",
        "pages": "33358-68",
        "reference": "21757739",
        "title": "Systematic identification of tubulin-interacting fragments of the microtubule-associated protein Tau leads to a highly efficient promoter of microtubule assembly.",
        "type": "PubMed",
        "volume": "286"
      },
      "evidence": "In the projection domain, an N-terminal extension and the first part of a proline-rich domain (PR1) are distinguished. The assembly domain consists of the second part of the proline-rich domain (PR2), three or four MTBRs, and a C-terminal extension with an upstream pseudo repeat R. The MTBRs are divided in repeats (R1 to R4) and inter-repeats (ir12, ir23, and ir34).",
      "key": "92840955afb53b79ccde908f3e371d6ef23b011b1d12a752f3985b9c38261d092715920ff759d98392cc493760b6a98eb46ef040b912364c739155bcb05c06f5",
      "line": 177,
      "relation": "equivalentTo",
      "source": 68,
      "target": 38
    },
    {
      "annotations": {
        "Method": {
          "NMR Spectroscopy": true
        }
      },
      "citation": {
        "authors": [
          "Fauquant C",
          "Gigant B",
          "Knossow M",
          "Landrieu I",
          "Laprévote O",
          "Lippens G",
          "Redeker V",
          "Verdegem D",
          "Wieruszeski JM"
        ],
        "date": "2011-09-23",
        "first": "Fauquant C",
        "last": "Knossow M",
        "name": "The Journal of biological chemistry",
        "pages": "33358-68",
        "reference": "21757739",
        "title": "Systematic identification of tubulin-interacting fragments of the microtubule-associated protein Tau leads to a highly efficient promoter of microtubule assembly.",
        "type": "PubMed",
        "volume": "286"
      },
      "evidence": "In the projection domain, an N-terminal extension and the first part of a proline-rich domain (PR1) are distinguished. The assembly domain consists of the second part of the proline-rich domain (PR2), three or four MTBRs, and a C-terminal extension with an upstream pseudo repeat R. The MTBRs are divided in repeats (R1 to R4) and inter-repeats (ir12, ir23, and ir34).",
      "key": "c8b516cc6e7ad853c84979d9dd7b6c9eaf6c3e1f3ab1d2f8668f08fed03196a3980e68468e6ace504d4d1f7b44a848c06c29dc2aa95cd13440d9250f6a161c99",
      "line": 179,
      "relation": "equivalentTo",
      "source": 71,
      "target": 39
    },
    {
      "annotations": {
        "Method": {
          "NMR Spectroscopy": true
        }
      },
      "citation": {
        "authors": [
          "Fauquant C",
          "Gigant B",
          "Knossow M",
          "Landrieu I",
          "Laprévote O",
          "Lippens G",
          "Redeker V",
          "Verdegem D",
          "Wieruszeski JM"
        ],
        "date": "2011-09-23",
        "first": "Fauquant C",
        "last": "Knossow M",
        "name": "The Journal of biological chemistry",
        "pages": "33358-68",
        "reference": "21757739",
        "title": "Systematic identification of tubulin-interacting fragments of the microtubule-associated protein Tau leads to a highly efficient promoter of microtubule assembly.",
        "type": "PubMed",
        "volume": "286"
      },
      "evidence": "In the projection domain, an N-terminal extension and the first part of a proline-rich domain (PR1) are distinguished. The assembly domain consists of the second part of the proline-rich domain (PR2), three or four MTBRs, and a C-terminal extension with an upstream pseudo repeat R. The MTBRs are divided in repeats (R1 to R4) and inter-repeats (ir12, ir23, and ir34).",
      "key": "7b1af2492ca06d9e9f76f679e6f1dbdda1ea06ba32ffb84cbb9534e0cfff4e5bd49a9c6cddf259fc3814bdd97ae9c918f82c3f5fa57cce4ff675bf7eb6bab4ab",
      "line": 181,
      "relation": "partOf",
      "source": 72,
      "target": 38
    },
    {
      "annotations": {
        "Method": {
          "NMR Spectroscopy": true
        }
      },
      "citation": {
        "authors": [
          "Fauquant C",
          "Gigant B",
          "Knossow M",
          "Landrieu I",
          "Laprévote O",
          "Lippens G",
          "Redeker V",
          "Verdegem D",
          "Wieruszeski JM"
        ],
        "date": "2011-09-23",
        "first": "Fauquant C",
        "last": "Knossow M",
        "name": "The Journal of biological chemistry",
        "pages": "33358-68",
        "reference": "21757739",
        "title": "Systematic identification of tubulin-interacting fragments of the microtubule-associated protein Tau leads to a highly efficient promoter of microtubule assembly.",
        "type": "PubMed",
        "volume": "286"
      },
      "evidence": "In the projection domain, an N-terminal extension and the first part of a proline-rich domain (PR1) are distinguished. The assembly domain consists of the second part of the proline-rich domain (PR2), three or four MTBRs, and a C-terminal extension with an upstream pseudo repeat R. The MTBRs are divided in repeats (R1 to R4) and inter-repeats (ir12, ir23, and ir34).",
      "key": "85d376a14617e70ead45b0f5a72960ac4132ad7d98d278aa02168c27bbbe3ebb8a42b0475170d910e542b0472b8f264435da14417589966a1b23a27fdd569fce",
      "line": 182,
      "relation": "equivalentTo",
      "source": 43,
      "target": 66
    },
    {
      "annotations": {
        "Method": {
          "NMR Spectroscopy": true
        }
      },
      "citation": {
        "authors": [
          "Fauquant C",
          "Gigant B",
          "Knossow M",
          "Landrieu I",
          "Laprévote O",
          "Lippens G",
          "Redeker V",
          "Verdegem D",
          "Wieruszeski JM"
        ],
        "date": "2011-09-23",
        "first": "Fauquant C",
        "last": "Knossow M",
        "name": "The Journal of biological chemistry",
        "pages": "33358-68",
        "reference": "21757739",
        "title": "Systematic identification of tubulin-interacting fragments of the microtubule-associated protein Tau leads to a highly efficient promoter of microtubule assembly.",
        "type": "PubMed",
        "volume": "286"
      },
      "evidence": "In the projection domain, an N-terminal extension and the first part of a proline-rich domain (PR1) are distinguished. The assembly domain consists of the second part of the proline-rich domain (PR2), three or four MTBRs, and a C-terminal extension with an upstream pseudo repeat R. The MTBRs are divided in repeats (R1 to R4) and inter-repeats (ir12, ir23, and ir34).",
      "key": "1fb2512200ddb638040b7dfefdadc55954789e84cbbd0e43b93e7cbc9aa7a073a9636331a801ee6395b21088b49d1b35237ffcc698be9a0dd9a8205d760584d6",
      "line": 183,
      "relation": "partOf",
      "source": 43,
      "target": 38
    },
    {
      "annotations": {
        "Method": {
          "NMR Spectroscopy": true
        }
      },
      "citation": {
        "authors": [
          "Fauquant C",
          "Gigant B",
          "Knossow M",
          "Landrieu I",
          "Laprévote O",
          "Lippens G",
          "Redeker V",
          "Verdegem D",
          "Wieruszeski JM"
        ],
        "date": "2011-09-23",
        "first": "Fauquant C",
        "last": "Knossow M",
        "name": "The Journal of biological chemistry",
        "pages": "33358-68",
        "reference": "21757739",
        "title": "Systematic identification of tubulin-interacting fragments of the microtubule-associated protein Tau leads to a highly efficient promoter of microtubule assembly.",
        "type": "PubMed",
        "volume": "286"
      },
      "evidence": "In the projection domain, an N-terminal extension and the first part of a proline-rich domain (PR1) are distinguished. The assembly domain consists of the second part of the proline-rich domain (PR2), three or four MTBRs, and a C-terminal extension with an upstream pseudo repeat R. The MTBRs are divided in repeats (R1 to R4) and inter-repeats (ir12, ir23, and ir34).",
      "key": "1678c0896651d702fd2061a7b6f6f7dd80af69afd2da4cf01dd48e5598d1102ef5d703452895305ba7e87872c3e8816ad75a09823207deacacc10f9f68d66b82",
      "line": 184,
      "relation": "partOf",
      "source": 43,
      "target": 41
    },
    {
      "annotations": {
        "Method": {
          "NMR Spectroscopy": true
        }
      },
      "citation": {
        "authors": [
          "Fauquant C",
          "Gigant B",
          "Knossow M",
          "Landrieu I",
          "Laprévote O",
          "Lippens G",
          "Redeker V",
          "Verdegem D",
          "Wieruszeski JM"
        ],
        "date": "2011-09-23",
        "first": "Fauquant C",
        "last": "Knossow M",
        "name": "The Journal of biological chemistry",
        "pages": "33358-68",
        "reference": "21757739",
        "title": "Systematic identification of tubulin-interacting fragments of the microtubule-associated protein Tau leads to a highly efficient promoter of microtubule assembly.",
        "type": "PubMed",
        "volume": "286"
      },
      "evidence": "In the projection domain, an N-terminal extension and the first part of a proline-rich domain (PR1) are distinguished. The assembly domain consists of the second part of the proline-rich domain (PR2), three or four MTBRs, and a C-terminal extension with an upstream pseudo repeat R. The MTBRs are divided in repeats (R1 to R4) and inter-repeats (ir12, ir23, and ir34).",
      "key": "5549621898c057c4b2949cd0ab11cb649ba8a9b0d591662f3f5af52080ec08288c2288371d267a662f80eddc79ed51bccf1414c3216bcb0db4dd89518c3f51ec",
      "line": 182,
      "relation": "equivalentTo",
      "source": 66,
      "target": 43
    },
    {
      "annotations": {
        "Method": {
          "NMR Spectroscopy": true
        }
      },
      "citation": {
        "authors": [
          "Fauquant C",
          "Gigant B",
          "Knossow M",
          "Landrieu I",
          "Laprévote O",
          "Lippens G",
          "Redeker V",
          "Verdegem D",
          "Wieruszeski JM"
        ],
        "date": "2011-09-23",
        "first": "Fauquant C",
        "last": "Knossow M",
        "name": "The Journal of biological chemistry",
        "pages": "33358-68",
        "reference": "21757739",
        "title": "Systematic identification of tubulin-interacting fragments of the microtubule-associated protein Tau leads to a highly efficient promoter of microtubule assembly.",
        "type": "PubMed",
        "volume": "286"
      },
      "evidence": "In the projection domain, an N-terminal extension and the first part of a proline-rich domain (PR1) are distinguished. The assembly domain consists of the second part of the proline-rich domain (PR2), three or four MTBRs, and a C-terminal extension with an upstream pseudo repeat R. The MTBRs are divided in repeats (R1 to R4) and inter-repeats (ir12, ir23, and ir34).",
      "key": "c186b0af418bcb0a098ad1a2279018bb03880bc06151d17da05fc6fa97508013ec1e17cc6f361972bf94261a9e5386313c2e2a9fb2c6345b8922ba6ae940e611",
      "line": 185,
      "relation": "equivalentTo",
      "source": 41,
      "target": 89
    },
    {
      "annotations": {
        "Method": {
          "NMR Spectroscopy": true
        }
      },
      "citation": {
        "authors": [
          "Fauquant C",
          "Gigant B",
          "Knossow M",
          "Landrieu I",
          "Laprévote O",
          "Lippens G",
          "Redeker V",
          "Verdegem D",
          "Wieruszeski JM"
        ],
        "date": "2011-09-23",
        "first": "Fauquant C",
        "last": "Knossow M",
        "name": "The Journal of biological chemistry",
        "pages": "33358-68",
        "reference": "21757739",
        "title": "Systematic identification of tubulin-interacting fragments of the microtubule-associated protein Tau leads to a highly efficient promoter of microtubule assembly.",
        "type": "PubMed",
        "volume": "286"
      },
      "evidence": "In the projection domain, an N-terminal extension and the first part of a proline-rich domain (PR1) are distinguished. The assembly domain consists of the second part of the proline-rich domain (PR2), three or four MTBRs, and a C-terminal extension with an upstream pseudo repeat R. The MTBRs are divided in repeats (R1 to R4) and inter-repeats (ir12, ir23, and ir34).",
      "key": "ca9af4a5fd4d574b92f72d346f4a9c4a49963157c6ef9c172ab2ea60782baa912feb03f55b0aad3e968eb0aa33c5593562f96f10a1ed91c77348c275fb6b5a4d",
      "line": 185,
      "relation": "equivalentTo",
      "source": 89,
      "target": 41
    },
    {
      "annotations": {
        "Method": {
          "NMR Spectroscopy": true
        }
      },
      "citation": {
        "authors": [
          "Fauquant C",
          "Gigant B",
          "Knossow M",
          "Landrieu I",
          "Laprévote O",
          "Lippens G",
          "Redeker V",
          "Verdegem D",
          "Wieruszeski JM"
        ],
        "date": "2011-09-23",
        "first": "Fauquant C",
        "last": "Knossow M",
        "name": "The Journal of biological chemistry",
        "pages": "33358-68",
        "reference": "21757739",
        "title": "Systematic identification of tubulin-interacting fragments of the microtubule-associated protein Tau leads to a highly efficient promoter of microtubule assembly.",
        "type": "PubMed",
        "volume": "286"
      },
      "evidence": "In the projection domain, an N-terminal extension and the first part of a proline-rich domain (PR1) are distinguished. The assembly domain consists of the second part of the proline-rich domain (PR2), three or four MTBRs, and a C-terminal extension with an upstream pseudo repeat R. The MTBRs are divided in repeats (R1 to R4) and inter-repeats (ir12, ir23, and ir34).",
      "key": "0046be304c4bb1dda3bc21835ed97cf6da9d722ab586739efbe1abdd829a67266a9aadd4f30bdcc43e75c4832ca04580947471208cfa147c7f953e617b49731c",
      "line": 186,
      "relation": "equivalentTo",
      "source": 42,
      "target": 65
    },
    {
      "annotations": {
        "Method": {
          "NMR Spectroscopy": true
        }
      },
      "citation": {
        "authors": [
          "Fauquant C",
          "Gigant B",
          "Knossow M",
          "Landrieu I",
          "Laprévote O",
          "Lippens G",
          "Redeker V",
          "Verdegem D",
          "Wieruszeski JM"
        ],
        "date": "2011-09-23",
        "first": "Fauquant C",
        "last": "Knossow M",
        "name": "The Journal of biological chemistry",
        "pages": "33358-68",
        "reference": "21757739",
        "title": "Systematic identification of tubulin-interacting fragments of the microtubule-associated protein Tau leads to a highly efficient promoter of microtubule assembly.",
        "type": "PubMed",
        "volume": "286"
      },
      "evidence": "In the projection domain, an N-terminal extension and the first part of a proline-rich domain (PR1) are distinguished. The assembly domain consists of the second part of the proline-rich domain (PR2), three or four MTBRs, and a C-terminal extension with an upstream pseudo repeat R. The MTBRs are divided in repeats (R1 to R4) and inter-repeats (ir12, ir23, and ir34).",
      "key": "29118f645700f36fa8a96b1376b34d157883d322eab74975956b11572420a823e7a5e994e773049b90c34dc815152160651106a2a43afd039512a43e5924f44a",
      "line": 187,
      "relation": "partOf",
      "source": 42,
      "target": 41
    },
    {
      "annotations": {
        "Method": {
          "NMR Spectroscopy": true
        }
      },
      "citation": {
        "authors": [
          "Fauquant C",
          "Gigant B",
          "Knossow M",
          "Landrieu I",
          "Laprévote O",
          "Lippens G",
          "Redeker V",
          "Verdegem D",
          "Wieruszeski JM"
        ],
        "date": "2011-09-23",
        "first": "Fauquant C",
        "last": "Knossow M",
        "name": "The Journal of biological chemistry",
        "pages": "33358-68",
        "reference": "21757739",
        "title": "Systematic identification of tubulin-interacting fragments of the microtubule-associated protein Tau leads to a highly efficient promoter of microtubule assembly.",
        "type": "PubMed",
        "volume": "286"
      },
      "evidence": "In the projection domain, an N-terminal extension and the first part of a proline-rich domain (PR1) are distinguished. The assembly domain consists of the second part of the proline-rich domain (PR2), three or four MTBRs, and a C-terminal extension with an upstream pseudo repeat R. The MTBRs are divided in repeats (R1 to R4) and inter-repeats (ir12, ir23, and ir34).",
      "key": "9d90eff690302353fed616b75426a1282f9b3b699ba11922a001c3c47ddcf0d0a4ed10bae06a2688f2bb6572ad258dd66dd055188c2e1e36ab6badf6bc4e3669",
      "line": 188,
      "relation": "partOf",
      "source": 42,
      "target": 40
    },
    {
      "annotations": {
        "Method": {
          "NMR Spectroscopy": true
        }
      },
      "citation": {
        "authors": [
          "Fauquant C",
          "Gigant B",
          "Knossow M",
          "Landrieu I",
          "Laprévote O",
          "Lippens G",
          "Redeker V",
          "Verdegem D",
          "Wieruszeski JM"
        ],
        "date": "2011-09-23",
        "first": "Fauquant C",
        "last": "Knossow M",
        "name": "The Journal of biological chemistry",
        "pages": "33358-68",
        "reference": "21757739",
        "title": "Systematic identification of tubulin-interacting fragments of the microtubule-associated protein Tau leads to a highly efficient promoter of microtubule assembly.",
        "type": "PubMed",
        "volume": "286"
      },
      "evidence": "In the projection domain, an N-terminal extension and the first part of a proline-rich domain (PR1) are distinguished. The assembly domain consists of the second part of the proline-rich domain (PR2), three or four MTBRs, and a C-terminal extension with an upstream pseudo repeat R. The MTBRs are divided in repeats (R1 to R4) and inter-repeats (ir12, ir23, and ir34).",
      "key": "04b2cfce4c1c7fe8b8c4bf2c4668f6f010f14a9ac8a12ef9a86724ea54da2d1d50bffff4e905886f5239a4fdebb26f3313565dcca891f15abeb277b44339bff3",
      "line": 186,
      "relation": "equivalentTo",
      "source": 65,
      "target": 42
    },
    {
      "annotations": {
        "Method": {
          "NMR Spectroscopy": true
        }
      },
      "citation": {
        "authors": [
          "Fauquant C",
          "Gigant B",
          "Knossow M",
          "Landrieu I",
          "Laprévote O",
          "Lippens G",
          "Redeker V",
          "Verdegem D",
          "Wieruszeski JM"
        ],
        "date": "2011-09-23",
        "first": "Fauquant C",
        "last": "Knossow M",
        "name": "The Journal of biological chemistry",
        "pages": "33358-68",
        "reference": "21757739",
        "title": "Systematic identification of tubulin-interacting fragments of the microtubule-associated protein Tau leads to a highly efficient promoter of microtubule assembly.",
        "type": "PubMed",
        "volume": "286"
      },
      "evidence": "In the projection domain, an N-terminal extension and the first part of a proline-rich domain (PR1) are distinguished. The assembly domain consists of the second part of the proline-rich domain (PR2), three or four MTBRs, and a C-terminal extension with an upstream pseudo repeat R. The MTBRs are divided in repeats (R1 to R4) and inter-repeats (ir12, ir23, and ir34).",
      "key": "07be16316e498ad1b27adeae0a28715f479906d1ef26c459e9a64f811129532f6c16501fae8b288a6f15f75c5cde29ed2cc03121fbfc70f4a2677655b0d5aa16",
      "line": 190,
      "relation": "partOf",
      "source": 69,
      "target": 40
    },
    {
      "annotations": {
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "Phosphatidylinositol binding clathrin assembly protein, PICALM (aka CALM) assembles adaptor protein-2 (AP-2) to clathrin, thus participating in clathrin-mediated endocytosis. We have previously reported that the level of full-length PICALM is decreased in AD brains; PICALM was co-localised with phosphorylated tau in NFTs and in granulovacuolar degenerations (GVDs) in the brains of AD patients and of individuals with Down syndrome but was not observed in amyloid plaques (Ando et al., 2013).",
      "key": "997150c5f9aeb8ad53aa713c4da4c372f38722cde9d36ac3e944f818433155bc7db7891ede3b14240876eba7258749ececdb58d1897fbf3a695d92ff9824f69b",
      "line": 204,
      "relation": "increases",
      "source": 82,
      "target": 20
    },
    {
      "annotations": {
        "Disease": {
          "Alzheimer's disease": true,
          "Down syndrome": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "Phosphatidylinositol binding clathrin assembly protein, PICALM (aka CALM) assembles adaptor protein-2 (AP-2) to clathrin, thus participating in clathrin-mediated endocytosis. We have previously reported that the level of full-length PICALM is decreased in AD brains; PICALM was co-localised with phosphorylated tau in NFTs and in granulovacuolar degenerations (GVDs) in the brains of AD patients and of individuals with Down syndrome but was not observed in amyloid plaques (Ando et al., 2013).",
      "key": "16d1d92bac3778cb4f8bda30281081cbe3cbe74719c63e21672150ce12daed544baf52f063d07a3e9d733a624b5021972a9fb20024eaff9e8e0e4ccf0c5a29e4",
      "line": 219,
      "relation": "negativeCorrelation",
      "source": 82,
      "target": 91
    },
    {
      "annotations": {
        "Disease": {
          "Alzheimer's disease": true,
          "Down syndrome": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "Phosphatidylinositol binding clathrin assembly protein, PICALM (aka CALM) assembles adaptor protein-2 (AP-2) to clathrin, thus participating in clathrin-mediated endocytosis. We have previously reported that the level of full-length PICALM is decreased in AD brains; PICALM was co-localised with phosphorylated tau in NFTs and in granulovacuolar degenerations (GVDs) in the brains of AD patients and of individuals with Down syndrome but was not observed in amyloid plaques (Ando et al., 2013).",
      "key": "3533a4b91389b2f3737f1449039af5fb40efe754bf244d0e95564627e3240b048dfcdee9c5f378916383239ef1dc22c9dab5d47c7ad67badd345f69dd189ef2d",
      "line": 220,
      "relation": "partOf",
      "source": 82,
      "target": 17
    },
    {
      "annotations": {
        "Anatomy": {
          "striatum": true
        },
        "Disease": {
          "progressive supranuclear palsy": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "In PSP cases, both coiled bodies (Fig. 2 D-F) and NFTs (Fig. 2G-I) in the striatum showed a complete co-localisation of PICALM and phosphotau immunoreactivies.",
      "key": "38aadc978eb14e1fc1b9fa962f62a9954bc6d4804b10ef1ed15b260916dc447e2f969174b954036de56bd4c3afdf1f1d444c42e0958c6e7ff94b0f9a4664652e",
      "line": 238,
      "relation": "partOf",
      "source": 82,
      "target": 17
    },
    {
      "annotations": {
        "Disease": {
          "Alzheimer's disease": true,
          "Down syndrome": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "Phosphatidylinositol binding clathrin assembly protein, PICALM (aka CALM) assembles adaptor protein-2 (AP-2) to clathrin, thus participating in clathrin-mediated endocytosis. We have previously reported that the level of full-length PICALM is decreased in AD brains; PICALM was co-localised with phosphorylated tau in NFTs and in granulovacuolar degenerations (GVDs) in the brains of AD patients and of individuals with Down syndrome but was not observed in amyloid plaques (Ando et al., 2013).",
      "key": "a7ea98aad6f927db35ca9a44c9da4f4473d14e1349a5732000b8586658c03a29dbec4e0289ad621a4d766b96fc9ea3838a92ef5bda172eca4bb6bd93aa637305",
      "line": 222,
      "relation": "association",
      "source": 82,
      "target": 73
    },
    {
      "annotations": {
        "Anatomy": {
          "striatum": true
        },
        "Disease": {
          "progressive supranuclear palsy": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "In PSP cases, both coiled bodies (Fig. 2 D-F) and NFTs (Fig. 2G-I) in the striatum showed a complete co-localisation of PICALM and phosphotau immunoreactivies.",
      "key": "b37a6798e7294687bf4abab4e2ad1817f4a948cd73a6ca33b2357a5db390b7e67b0986ca23b1a4cfb011c720242d0ef3616a735ff8aa23bb26bf32ced7c07b74",
      "line": 240,
      "relation": "association",
      "source": 82,
      "target": 73
    },
    {
      "annotations": {
        "Disease": {
          "Alzheimer's disease": true,
          "Down syndrome": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "Phosphatidylinositol binding clathrin assembly protein, PICALM (aka CALM) assembles adaptor protein-2 (AP-2) to clathrin, thus participating in clathrin-mediated endocytosis. We have previously reported that the level of full-length PICALM is decreased in AD brains; PICALM was co-localised with phosphorylated tau in NFTs and in granulovacuolar degenerations (GVDs) in the brains of AD patients and of individuals with Down syndrome but was not observed in amyloid plaques (Ando et al., 2013).",
      "key": "afb1be76d63b1d841cc166add99189f759bd7843193a1cd6eb4cdbfcc5d548aaf932536965045f1af9117711bb40463493dbfb365e2741b923a24b6a33e05e75",
      "line": 223,
      "relation": "partOf",
      "source": 82,
      "target": 90
    },
    {
      "annotations": {
        "Disease": {
          "Pick's disease": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "Double immunostaining for PICALM and anti-phosphotau antibodies (AT8 and PHF1) showed a co-localisation of PICALM and phosphotau in Pick bodies of Pick disease",
      "key": "6245a5ccd770a7590a432f81b1fe5c2c16a170d3f7c2622ff4a1a3ff59b933fce3b82faf6e3b2b450df6a2d3977b7b879e4ee9feab4c7ce6ca02704f5025b5c6",
      "line": 229,
      "relation": "partOf",
      "source": 82,
      "target": 15
    },
    {
      "annotations": {
        "Anatomy": {
          "striatum": true
        },
        "Disease": {
          "progressive supranuclear palsy": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "In PSP cases, both coiled bodies (Fig. 2 D-F) and NFTs (Fig. 2G-I) in the striatum showed a complete co-localisation of PICALM and phosphotau immunoreactivies.",
      "key": "df09947a5c3b1ccfb944f957207573fe9cbc2bc67e9121cb6a794e730531f3de24b797af4924e06cac2efca786c6b12834bfbd170ec35b9da283bde91f4a5a19",
      "line": 241,
      "relation": "partOf",
      "source": 82,
      "target": 14
    },
    {
      "annotations": {
        "Disease": {
          "Alzheimer's disease": true,
          "Down syndrome": true,
          "Pick's disease": true,
          "progressive supranuclear palsy": true
        },
        "HBP_Disease": {
          "Corticobasal Degeneration": true,
          "Frontotemporal Lobar Degeneration": true,
          "Lewy Body Disease, Diffuse": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "A highly significant correlation was found between decreased levels of PICALM and increased levels of LC3-II (p=0.0032) or decreased levels of Beclin-1 (p=0.0295) in the total brain lysates from these diseases (Fig 6D,E).",
      "key": "9d0e3f43a25295e617676ac824bcadcec15ad8ef9447e74451791a0dc1a6bbce7b43ed0606ca57070c2b62f44664a8c77f94b25a00c04f63436876802f2e8099",
      "line": 250,
      "relation": "negativeCorrelation",
      "source": 82,
      "target": 63
    },
    {
      "annotations": {
        "Disease": {
          "Alzheimer's disease": true,
          "Down syndrome": true,
          "Pick's disease": true,
          "progressive supranuclear palsy": true
        },
        "HBP_Disease": {
          "Corticobasal Degeneration": true,
          "Frontotemporal Lobar Degeneration": true,
          "Lewy Body Disease, Diffuse": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "A highly significant correlation was found between decreased levels of PICALM and increased levels of LC3-II (p=0.0032) or decreased levels of Beclin-1 (p=0.0295) in the total brain lysates from these diseases (Fig 6D,E).",
      "key": "3735c8ca7fa65389846b46d9d270f57b25cfcd468b83de496dda53c19cfcb9c709dcbab0b1b6093edcbce904608ddffce9312a585f2befec3e0dda6d672475e8",
      "line": 251,
      "relation": "positiveCorrelation",
      "source": 82,
      "target": 58
    },
    {
      "key": "5746dae6e85832fc577c8ca30645f17d4d26cea18021e8ed3d34ec1515001db2afa3661e471088a531d154b89cfdfb5a1441992a0f32f7ce465c2ffc0d911e07",
      "relation": "hasComponent",
      "source": 20,
      "target": 24
    },
    {
      "key": "b1f5108aea1b92266c120ff627021b1ddfab411c28ec65839ad09bac11801836a02e92a4131a4e6a2887724cd329248dda876b51eb3563fc7078fd531b77dede",
      "relation": "hasComponent",
      "source": 20,
      "target": 84
    },
    {
      "annotations": {
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "Phosphatidylinositol binding clathrin assembly protein, PICALM (aka CALM) assembles adaptor protein-2 (AP-2) to clathrin, thus participating in clathrin-mediated endocytosis. We have previously reported that the level of full-length PICALM is decreased in AD brains; PICALM was co-localised with phosphorylated tau in NFTs and in granulovacuolar degenerations (GVDs) in the brains of AD patients and of individuals with Down syndrome but was not observed in amyloid plaques (Ando et al., 2013).",
      "key": "fb89f5a0b97aca9a83d324afb95b479e007104c1bc5e44207f052c68b7013c3bebe0427c03a30b3d6cb2471bef2a27a66fbfb18d455099c5d37ceae96b610e1e",
      "line": 205,
      "relation": "positiveCorrelation",
      "source": 20,
      "target": 11
    },
    {
      "annotations": {
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "Phosphatidylinositol binding clathrin assembly protein, PICALM (aka CALM) assembles adaptor protein-2 (AP-2) to clathrin, thus participating in clathrin-mediated endocytosis. We have previously reported that the level of full-length PICALM is decreased in AD brains; PICALM was co-localised with phosphorylated tau in NFTs and in granulovacuolar degenerations (GVDs) in the brains of AD patients and of individuals with Down syndrome but was not observed in amyloid plaques (Ando et al., 2013).",
      "key": "57710bf8f554eaf3febeb83bd3e08dfaf3c4432f2f8c8cf73edc2b55cc2f41ffcbf9c1c30d250e4b6d73612e134521981336b88f6c33eb580cc2a3d3fef12c85",
      "line": 205,
      "relation": "positiveCorrelation",
      "source": 11,
      "target": 20
    },
    {
      "annotations": {
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "Phosphatidylinositol binding clathrin assembly protein, PICALM (aka CALM) assembles adaptor protein-2 (AP-2) to clathrin, thus participating in clathrin-mediated endocytosis. We have previously reported that the level of full-length PICALM is decreased in AD brains; PICALM was co-localised with phosphorylated tau in NFTs and in granulovacuolar degenerations (GVDs) in the brains of AD patients and of individuals with Down syndrome but was not observed in amyloid plaques (Ando et al., 2013).",
      "key": "bb1cfe03a9a4a4715cff7605301c729e0b727ed1691ae9e0170d4c730bd1b53f18ea78e79c1ab52a18c966c77d9d193cd47dc9996af7c9bbc123a78af578ba88",
      "line": 209,
      "relation": "partOf",
      "source": 56,
      "target": 24
    },
    {
      "annotations": {
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "Phosphatidylinositol binding clathrin assembly protein, PICALM (aka CALM) assembles adaptor protein-2 (AP-2) to clathrin, thus participating in clathrin-mediated endocytosis. We have previously reported that the level of full-length PICALM is decreased in AD brains; PICALM was co-localised with phosphorylated tau in NFTs and in granulovacuolar degenerations (GVDs) in the brains of AD patients and of individuals with Down syndrome but was not observed in amyloid plaques (Ando et al., 2013).",
      "key": "a7a9898480639c66532dd286c5e2c5a412d347dc225192af53f961fe8e4ae6eed4aa56d2cd57625ba2f9560785b4c37965949b0fed7bce9f40c4b43d77e36aec",
      "line": 210,
      "relation": "partOf",
      "source": 55,
      "target": 24
    },
    {
      "annotations": {
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "Phosphatidylinositol binding clathrin assembly protein, PICALM (aka CALM) assembles adaptor protein-2 (AP-2) to clathrin, thus participating in clathrin-mediated endocytosis. We have previously reported that the level of full-length PICALM is decreased in AD brains; PICALM was co-localised with phosphorylated tau in NFTs and in granulovacuolar degenerations (GVDs) in the brains of AD patients and of individuals with Down syndrome but was not observed in amyloid plaques (Ando et al., 2013).",
      "key": "6c7e6c02aa4d5b0e25ef1d1bef8f42ef223c84007e29b1955a9aa1ad3a94950efaa973bd81cb2a98314dd5418e24a4f9578e8761530b3bffd0b0a1b556df9756",
      "line": 211,
      "relation": "partOf",
      "source": 53,
      "target": 24
    },
    {
      "annotations": {
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "Phosphatidylinositol binding clathrin assembly protein, PICALM (aka CALM) assembles adaptor protein-2 (AP-2) to clathrin, thus participating in clathrin-mediated endocytosis. We have previously reported that the level of full-length PICALM is decreased in AD brains; PICALM was co-localised with phosphorylated tau in NFTs and in granulovacuolar degenerations (GVDs) in the brains of AD patients and of individuals with Down syndrome but was not observed in amyloid plaques (Ando et al., 2013).",
      "key": "399a96fd0ee59626df3e155fc499881b74b78d8575f90ea72c95f84d4a89b514bcee395bb0bbaeaf0f433014c72d9278388c1ed189aa569ce902028e13671b92",
      "line": 212,
      "relation": "partOf",
      "source": 54,
      "target": 24
    },
    {
      "annotations": {
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "Phosphatidylinositol binding clathrin assembly protein, PICALM (aka CALM) assembles adaptor protein-2 (AP-2) to clathrin, thus participating in clathrin-mediated endocytosis. We have previously reported that the level of full-length PICALM is decreased in AD brains; PICALM was co-localised with phosphorylated tau in NFTs and in granulovacuolar degenerations (GVDs) in the brains of AD patients and of individuals with Down syndrome but was not observed in amyloid plaques (Ando et al., 2013).",
      "key": "ccd39c5041ca13688adf9107eb8e4b914d49edfc77831a4f5e0efe9f1beef6601ea3463c445373934f267e69606a88f2b2e5173c90c37933f85f310d6e4a6283",
      "line": 213,
      "relation": "partOf",
      "source": 57,
      "target": 24
    },
    {
      "annotations": {
        "Disease": {
          "Alzheimer's disease": true,
          "Down syndrome": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "Phosphatidylinositol binding clathrin assembly protein, PICALM (aka CALM) assembles adaptor protein-2 (AP-2) to clathrin, thus participating in clathrin-mediated endocytosis. We have previously reported that the level of full-length PICALM is decreased in AD brains; PICALM was co-localised with phosphorylated tau in NFTs and in granulovacuolar degenerations (GVDs) in the brains of AD patients and of individuals with Down syndrome but was not observed in amyloid plaques (Ando et al., 2013).",
      "key": "5e9014f3a2d407b8b04b1454c20dc9f7b9e53d9de0cb9013ca8b52ebae3d38928197efc12c09a83de51afac08b2203363ebae9eec3542e180d3f3a97ee853842",
      "line": 219,
      "relation": "negativeCorrelation",
      "source": 91,
      "target": 82
    },
    {
      "annotations": {
        "Anatomy": {
          "visual cortex": true
        },
        "MeSHDisease": {
          "Frontotemporal Dementia": true
        },
        "Method": {
          "In-vivo two photon calcium imaging": true
        },
        "MouseStrain": {
          "rTg4510": true
        },
        "Species": {
          "10090": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Andermann ML",
          "Bacskai BJ",
          "Hawkes J",
          "Hyman BT",
          "Kopeikina KJ",
          "Kuchibhotla KV",
          "Rudinskiy N",
          "Spires-Jones TL",
          "Wegmann S"
        ],
        "date": "2014-01-07",
        "first": "Kuchibhotla KV",
        "last": "Hyman BT",
        "name": "Proceedings of the National Academy of Sciences of the United States of America",
        "pages": "510-4",
        "reference": "24368848",
        "title": "Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo.",
        "type": "PubMed",
        "volume": "111"
      },
      "evidence": "We found that in the visual cortex, neurons containing conspicuous quantities of mislocalized and aggregated tau nonetheless appear to have a normal capacity to integrate dendritic inputs and respond robustly to visual stimuli and also maintain normal somatic baseline calcium levels. In particular, we show that individual NFT-bearing neurons can respond robustly after integrating sensory inputs and are functionally indistinguishable from neighboring non–NFT-bearing neurons. These results demonstrate that NFT-bearing neurons remain functionally integrated in cortical circuits.",
      "key": "4eb0839556ae2d3a3b3965b7350e0888492a73d412e4d8baa81f470290abb59f58467f11e46a0c6cbefd83b551938de9cf84ab1f2280cc1b90f81647d16f8d80",
      "line": 273,
      "object": {
        "modifier": "Activity"
      },
      "relation": "causesNoChange",
      "source": 17,
      "target": 9
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "Dendritic arborization was abundant in RD3-/4+ pretangles, attenuated in RD3+/4+ neurons, and further attenuated in RD3+/4- ghost tangles.",
      "key": "08a72f0fa1b78c21a9457af2af0135169c42cbe4cf994269638d1114dad65b61728e92bdcb55e073529421dabb5ee9b1866f6e30cdf26fe3aba8df5813dad333",
      "line": 357,
      "relation": "decreases",
      "source": 17,
      "target": 16
    },
    {
      "annotations": {
        "Disease": {
          "Alzheimer's disease": true,
          "Down syndrome": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "Phosphatidylinositol binding clathrin assembly protein, PICALM (aka CALM) assembles adaptor protein-2 (AP-2) to clathrin, thus participating in clathrin-mediated endocytosis. We have previously reported that the level of full-length PICALM is decreased in AD brains; PICALM was co-localised with phosphorylated tau in NFTs and in granulovacuolar degenerations (GVDs) in the brains of AD patients and of individuals with Down syndrome but was not observed in amyloid plaques (Ando et al., 2013).",
      "key": "39117463caa3e8e857475330cf604cf9d6fb4ec5ac5bd18f103be795e7b5f0901754cc67566387a45b8604aaaedaff9d16aba884c5fa6aa647e8982158d8511c",
      "line": 221,
      "relation": "partOf",
      "source": 73,
      "target": 17
    },
    {
      "annotations": {
        "Anatomy": {
          "striatum": true
        },
        "Disease": {
          "progressive supranuclear palsy": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "In PSP cases, both coiled bodies (Fig. 2 D-F) and NFTs (Fig. 2G-I) in the striatum showed a complete co-localisation of PICALM and phosphotau immunoreactivies.",
      "key": "0a54d4fdccbacbdad4d97a31299580aac7e10a4ebf207422c15a0460a8276ae460a652005c336a7f098939e323d26a0eff12a9c94dea8deb3700b9590f215343",
      "line": 239,
      "relation": "partOf",
      "source": 73,
      "target": 17
    },
    {
      "annotations": {
        "Disease": {
          "Alzheimer's disease": true,
          "Down syndrome": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "Phosphatidylinositol binding clathrin assembly protein, PICALM (aka CALM) assembles adaptor protein-2 (AP-2) to clathrin, thus participating in clathrin-mediated endocytosis. We have previously reported that the level of full-length PICALM is decreased in AD brains; PICALM was co-localised with phosphorylated tau in NFTs and in granulovacuolar degenerations (GVDs) in the brains of AD patients and of individuals with Down syndrome but was not observed in amyloid plaques (Ando et al., 2013).",
      "key": "984c0e30d40958c82cc727bd7e5f36a21bfe07466c1c39735c95ff022e6d084e646376e2cfc800b1e58bc5880245e53f5c0254726f269978c39e35740dc68051",
      "line": 222,
      "relation": "association",
      "source": 73,
      "target": 82
    },
    {
      "annotations": {
        "Anatomy": {
          "striatum": true
        },
        "Disease": {
          "progressive supranuclear palsy": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "In PSP cases, both coiled bodies (Fig. 2 D-F) and NFTs (Fig. 2G-I) in the striatum showed a complete co-localisation of PICALM and phosphotau immunoreactivies.",
      "key": "7f14bafef49dafbdfdd4634402951abcff4ab7deb05d657c91dfe542d497394d46f09ae7cc80cd15e0d6c084c2668f53e57f5816a90c66000e9603810365fef0",
      "line": 240,
      "relation": "association",
      "source": 73,
      "target": 82
    },
    {
      "annotations": {
        "Disease": {
          "Pick's disease": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "Double immunostaining for PICALM and anti-phosphotau antibodies (AT8 and PHF1) showed a co-localisation of PICALM and phosphotau in Pick bodies of Pick disease",
      "key": "a829732ad8ddd1ac5413c72f71ce69c89268e7fd9b68bfd5111e1a37d4384431a89c6f6b6aa70ee28fc78a80ff66cb55852e4c3f6d570e3388253ac0325453c1",
      "line": 230,
      "relation": "partOf",
      "source": 73,
      "target": 15
    },
    {
      "annotations": {
        "Anatomy": {
          "striatum": true
        },
        "Disease": {
          "progressive supranuclear palsy": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "In PSP cases, both coiled bodies (Fig. 2 D-F) and NFTs (Fig. 2G-I) in the striatum showed a complete co-localisation of PICALM and phosphotau immunoreactivies.",
      "key": "9b8e8ec9d4959f34adead22628ecfe75e178537aef5413f7f7ae38bfb48faadbe340de25cafb056fc2487efa6c126d3000b46cade37225e0933127f1ede392d8",
      "line": 242,
      "relation": "partOf",
      "source": 73,
      "target": 14
    },
    {
      "annotations": {
        "Disease": {
          "Pick's disease": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "Double immunostaining for PICALM and anti-phosphotau antibodies (AT8 and PHF1) showed a co-localisation of PICALM and phosphotau in Pick bodies of Pick disease",
      "key": "13b07627f33e1011ba4d4effe23a75664a484fb3bd84ee7de159ae96519e80bca626dabca24046d9d9822ec569b836cf1075fbe28ab530d4a1ece99fb696b448",
      "line": 231,
      "relation": "positiveCorrelation",
      "source": 15,
      "target": 93
    },
    {
      "annotations": {
        "Disease": {
          "Pick's disease": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "Double immunostaining for PICALM and anti-phosphotau antibodies (AT8 and PHF1) showed a co-localisation of PICALM and phosphotau in Pick bodies of Pick disease",
      "key": "577973a95842f4adac41592260fd89d3ac7d3b8c3d016ae21b79cc7f0c0111852c97c38bf207a0c3dda8020121595963941e4f6c5b5fdf01ea83015cf68514e4",
      "line": 231,
      "relation": "positiveCorrelation",
      "source": 93,
      "target": 15
    },
    {
      "annotations": {
        "Disease": {
          "Alzheimer's disease": true,
          "Down syndrome": true,
          "Pick's disease": true,
          "progressive supranuclear palsy": true
        },
        "HBP_Disease": {
          "Corticobasal Degeneration": true,
          "Frontotemporal Lobar Degeneration": true,
          "Lewy Body Disease, Diffuse": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "A highly significant correlation was found between decreased levels of PICALM and increased levels of LC3-II (p=0.0032) or decreased levels of Beclin-1 (p=0.0295) in the total brain lysates from these diseases (Fig 6D,E).",
      "key": "e392ac56694441f16cf88d6f5ee9fdce080cf02890c02c99a607001ae7cfd52ffc3fb32698a44123080eb806ec49d52dfd895a92fb7e2b3b2d1e1a0116848ffa",
      "line": 250,
      "relation": "negativeCorrelation",
      "source": 63,
      "target": 82
    },
    {
      "annotations": {
        "Disease": {
          "Alzheimer's disease": true,
          "Down syndrome": true,
          "Pick's disease": true,
          "progressive supranuclear palsy": true
        },
        "HBP_Disease": {
          "Corticobasal Degeneration": true,
          "Frontotemporal Lobar Degeneration": true,
          "Lewy Body Disease, Diffuse": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Ando K",
          "Authelet M",
          "Belkouch M",
          "Brion JP",
          "Duyckaerts C",
          "Ndjim M",
          "Potier MC",
          "Sazdovitch V",
          "Suain V",
          "Tomimura K",
          "Vergara C",
          "Yilmaz Z"
        ],
        "date": "2016-10-01",
        "first": "Ando K",
        "last": "Brion JP",
        "name": "Neurobiology of disease",
        "pages": "32-43",
        "reference": "27260836",
        "title": "Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.",
        "type": "PubMed",
        "volume": "94"
      },
      "evidence": "A highly significant correlation was found between decreased levels of PICALM and increased levels of LC3-II (p=0.0032) or decreased levels of Beclin-1 (p=0.0295) in the total brain lysates from these diseases (Fig 6D,E).",
      "key": "dc078b6224f1337d033ed8b1d2ecc1bcb0e481d87c95ff677014638a56112bcb3761aabf21760b0583564a5f3da0d2ac400451735e6cbc643f20df0582f44dce",
      "line": 251,
      "relation": "positiveCorrelation",
      "source": 58,
      "target": 82
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Frontotemporal Dementia": true
        },
        "MouseStrain": {
          "rTg4510": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Andermann ML",
          "Bacskai BJ",
          "Hawkes J",
          "Hyman BT",
          "Kopeikina KJ",
          "Kuchibhotla KV",
          "Rudinskiy N",
          "Spires-Jones TL",
          "Wegmann S"
        ],
        "date": "2014-01-07",
        "first": "Kuchibhotla KV",
        "last": "Hyman BT",
        "name": "Proceedings of the National Academy of Sciences of the United States of America",
        "pages": "510-4",
        "reference": "24368848",
        "title": "Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo.",
        "type": "PubMed",
        "volume": "111"
      },
      "evidence": "We found that in the visual cortex, neurons containing conspicuous quantities of mislocalized and aggregated tau nonetheless appear to have a normal capacity to integrate dendritic inputs and respond robustly to visual stimuli and also maintain normal somatic baseline calcium levels. In particular, we show that individual NFT-bearing neurons can respond robustly after integrating sensory inputs and are functionally indistinguishable from neighboring non–NFT-bearing neurons. These results demonstrate that NFT-bearing neurons remain functionally integrated in cortical circuits.",
      "key": "ce1173b2847fbc4aa865a98ad499f0a04c020d176f8c7eb65ac6772bb287e9b5cf9562444187aff625f74d3f0f185dc62618a80375d5f844830ee069c0bcf246",
      "line": 269,
      "relation": "increases",
      "source": 34,
      "target": 92
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "Because tracing with anti-tau antibodies does not distinguish between its isoforms, i.e., three-repeat (3R) and four-repeat (4R) tau, it remains to be clarified how these isoforms are related to the evolution of each lesion and its spread.",
      "key": "d6913f0c174352412a76ffe6c575667837b4a9b0ed6e8cf32855736b679531bc499f829d58e3a4c6fa768cf8bdce92c5e702cb424827293d39cb62c4380c805c",
      "line": 305,
      "relation": "isA",
      "source": 23,
      "target": 64
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "In summary, the cytological evolution from pretangle neurons to NFTs and then to ghost tangles was accompanied by a profile shift from RD3-/4+ (pretangles) to RD3+/4+ (NFTs) and then to RD3+/4+ (ghost tangles).",
      "key": "8111f16fcd658db1aa4db34641c6246fe8fee6ef338accfd054e4d9dfb697747e8639cbd6b5bff9021deacd5edfe09f6652ef39fbaee7af1175cfa4663260c52",
      "line": 311,
      "relation": "partOf",
      "source": 23,
      "target": 7
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "In summary, the cytological evolution from pretangle neurons to NFTs and then to ghost tangles was accompanied by a profile shift from RD3-/4+ (pretangles) to RD3+/4+ (NFTs) and then to RD3+/4+ (ghost tangles).",
      "key": "8f993c54568da4fcc7598b04a3ef9f107f9f6277c0812e714160a137cfce3eded9d8a665ccc03f45826071deac116371909cee5a97ca75bf85378d2ce23a9477",
      "line": 313,
      "relation": "partOf",
      "source": 23,
      "target": 17
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoformGradient": {
          "4R-Very High": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "The RD3+/4- (red) fraction was consistently higher in EC and CA1, which was serially followed by CA2, CA3, and CA4. This trend was reversed with the RD3-/4+ (green) fraction, which was consistently highest in CA4, which was serially followed by CA3, CA2, CA1, and EC.",
      "key": "65c9a525d08c6e8e63e905e704ec6263be2a20be0c49279aa0c8a9cc2f917557f952c234a07febe577e52131b3dc9f25c1d6dde9577ca4e6776969c34dbd5f0d",
      "line": 330,
      "relation": "positiveCorrelation",
      "source": 23,
      "target": 4
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoformGradient": {
          "4R-High": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "The RD3+/4- (red) fraction was consistently higher in EC and CA1, which was serially followed by CA2, CA3, and CA4. This trend was reversed with the RD3-/4+ (green) fraction, which was consistently highest in CA4, which was serially followed by CA3, CA2, CA1, and EC.",
      "key": "9449919de4c96cfce3b08c46febf6409b6bfc51c07927382f56675f974b8cdb3740aa0f68e1cb9c5c299a49df37e748f30989096d66ceefd8eb542806f4f5384",
      "line": 332,
      "relation": "positiveCorrelation",
      "source": 23,
      "target": 3
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoformGradient": {
          "4R-Medium": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "The RD3+/4- (red) fraction was consistently higher in EC and CA1, which was serially followed by CA2, CA3, and CA4. This trend was reversed with the RD3-/4+ (green) fraction, which was consistently highest in CA4, which was serially followed by CA3, CA2, CA1, and EC.",
      "key": "bb6ae50e3ad0f04fbe7ce94be02cfd9acb3437608808c18f573995454526e16bb17b23f2bcc45cc64cda134b17b493ff4cf86e5111869cf30c3d0659451001b1",
      "line": 334,
      "relation": "positiveCorrelation",
      "source": 23,
      "target": 2
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoformGradient": {
          "4R-Low": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "The RD3+/4- (red) fraction was consistently higher in EC and CA1, which was serially followed by CA2, CA3, and CA4. This trend was reversed with the RD3-/4+ (green) fraction, which was consistently highest in CA4, which was serially followed by CA3, CA2, CA1, and EC.",
      "key": "7d70937f0524d1de2997e1796c4620756c79684a186bcae037f4b573220515bffe4cbb47967ddcbcaa02e6c353d0a16387241062329b0f4158a8c8d998fbe0d0",
      "line": 336,
      "relation": "positiveCorrelation",
      "source": 23,
      "target": 1
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoformGradient": {
          "4R-Low": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "The RD3+/4- (red) fraction was consistently higher in EC and CA1, which was serially followed by CA2, CA3, and CA4. This trend was reversed with the RD3-/4+ (green) fraction, which was consistently highest in CA4, which was serially followed by CA3, CA2, CA1, and EC.",
      "key": "3bb6da29da25c700385b0494f5fbaa80a3220a53bb4bc7b4f9adcac68165520eafdcc84ea2ca310b9d45c191f3f521153783d92b8540c40932494bd5183ddfe3",
      "line": 337,
      "relation": "positiveCorrelation",
      "source": 23,
      "target": 0
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoformGradient": {
          "4R-High": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "In addition to the mainly cytoplasmic IR of RD4, RD3 IR extended into more distal dendrites  and neuropil threads. This extended RD3 IR was not explained by its higher sensitivity, because RD4 IR was more intense in the cytoplasm than in the dendrites, while this gradient was reversed with RD3 IR (red).",
      "key": "3eaa2e12f05365de4c5c9ad6e65331ed77488d3452261a7b095514f15a1ed256e35d06e940d6e352ce7c093d30209e63b9127bd6cc6c9278ab81ada19357831a",
      "line": 347,
      "relation": "partOf",
      "source": 23,
      "target": 18
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoformGradient": {
          "4R-Low": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "In addition to the mainly cytoplasmic IR of RD4, RD3 IR extended into more distal dendrites  and neuropil threads. This extended RD3 IR was not explained by its higher sensitivity, because RD4 IR was more intense in the cytoplasm than in the dendrites, while this gradient was reversed with RD3 IR (red).",
      "key": "918976bfcef687e167cffbbe9c9c87e2081cb1938093d9d6a15ac9d1517f0354a90223b92a51cc0148ed0c670a56773f27e5db283da55caf5c6c8b90e1409cfb",
      "line": 351,
      "relation": "partOf",
      "source": 23,
      "target": 19
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoformGradient": {
          "4R-Low": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "In addition to the mainly cytoplasmic IR of RD4, RD3 IR extended into more distal dendrites  and neuropil threads. This extended RD3 IR was not explained by its higher sensitivity, because RD4 IR was more intense in the cytoplasm than in the dendrites, while this gradient was reversed with RD3 IR (red).",
      "key": "3dc797d22279b8255b34c9058f3c1156d257316eb6bc1f5a8503e7d7f8dbfba74844c87ab023bd7ac94242b8c586a020b05fe3f4365c6d5f30aff4820878ee46",
      "line": 352,
      "relation": "partOf",
      "source": 23,
      "target": 10
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "Because tracing with anti-tau antibodies does not distinguish between its isoforms, i.e., three-repeat (3R) and four-repeat (4R) tau, it remains to be clarified how these isoforms are related to the evolution of each lesion and its spread.",
      "key": "97f0858a2081ee460344703e6fa883c3d698a913e4891b830bc4def5ff09fba97198d3531a8032d2c86565bf558b30a0fdf8fc87a0d7b7948518f2472b476fb9",
      "line": 306,
      "relation": "isA",
      "source": 22,
      "target": 64
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "In summary, the cytological evolution from pretangle neurons to NFTs and then to ghost tangles was accompanied by a profile shift from RD3-/4+ (pretangles) to RD3+/4+ (NFTs) and then to RD3+/4+ (ghost tangles).",
      "key": "b0a22260f5edf9927073691f51ca387f8dba2f3e660e7d20fd34a4ecbf592929fa2bb63aac0b3ae880f0d5b8a4834d3708ec18c2ca0354de47c80a0a363ecc95",
      "line": 312,
      "relation": "partOf",
      "source": 22,
      "target": 17
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "In summary, the cytological evolution from pretangle neurons to NFTs and then to ghost tangles was accompanied by a profile shift from RD3-/4+ (pretangles) to RD3+/4+ (NFTs) and then to RD3+/4+ (ghost tangles).",
      "key": "4405269d08eb901ee8b304468d63e8a3548f540d1bc85b3b823552638d92c7394328b00cbf4917cbe47fcab1d416166cd483936c5a6fcb07eb20c58744f4d0b6",
      "line": 314,
      "relation": "partOf",
      "source": 22,
      "target": 6
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoformGradient": {
          "3R-Very High": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "The RD3+/4- (red) fraction was consistently higher in EC and CA1, which was serially followed by CA2, CA3, and CA4. This trend was reversed with the RD3-/4+ (green) fraction, which was consistently highest in CA4, which was serially followed by CA3, CA2, CA1, and EC.",
      "key": "0dc269ceea237fcc6755ff0411f2512018e3e738417480e7b3216e6368b2812bfb3df25f81fcae065edf615ad5e51d1ec52613d34f6a0f4cff570e253f4e12dd",
      "line": 321,
      "relation": "partOf",
      "source": 22,
      "target": 0
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoformGradient": {
          "3R-Very High": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "The RD3+/4- (red) fraction was consistently higher in EC and CA1, which was serially followed by CA2, CA3, and CA4. This trend was reversed with the RD3-/4+ (green) fraction, which was consistently highest in CA4, which was serially followed by CA3, CA2, CA1, and EC.",
      "key": "8c5c511a47e768790ea9f3c7afaa2a923564c4575899e91223f6e616cba705d9d6dac402af177ee74dc1ad64f9180c39c2d2a91a9dcfd9b6059153ef3ca76726",
      "line": 322,
      "relation": "partOf",
      "source": 22,
      "target": 1
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoformGradient": {
          "3R-High": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "The RD3+/4- (red) fraction was consistently higher in EC and CA1, which was serially followed by CA2, CA3, and CA4. This trend was reversed with the RD3-/4+ (green) fraction, which was consistently highest in CA4, which was serially followed by CA3, CA2, CA1, and EC.",
      "key": "425c1ffbe753e86ace5713f6d0a9b5c8c42bfe6d3941b6481fa67aa8e1abb6a644d686860dff792002d78738a9fb3db71d76a70569ff9130c5f9649d6376a5bc",
      "line": 324,
      "relation": "partOf",
      "source": 22,
      "target": 2
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoformGradient": {
          "3R-Medium": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "The RD3+/4- (red) fraction was consistently higher in EC and CA1, which was serially followed by CA2, CA3, and CA4. This trend was reversed with the RD3-/4+ (green) fraction, which was consistently highest in CA4, which was serially followed by CA3, CA2, CA1, and EC.",
      "key": "349774a9ab17043e9999f8fca29878497ac0c346f4d9b2d12960ce02f68777142323203811bbb9c8a3b9079f034583f0eff8506a259d68525fe8694e5dbeea0d",
      "line": 326,
      "relation": "partOf",
      "source": 22,
      "target": 3
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoformGradient": {
          "3R-Low": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "The RD3+/4- (red) fraction was consistently higher in EC and CA1, which was serially followed by CA2, CA3, and CA4. This trend was reversed with the RD3-/4+ (green) fraction, which was consistently highest in CA4, which was serially followed by CA3, CA2, CA1, and EC.",
      "key": "4a7fca3f68cd69998b3c443fa7903717288fad5ee32f7d839e07cc8018a22be38376cd8d8424024f018b86a44c54f6c348a1c7bce3fe6cfc340fba5cdfb0f645",
      "line": 328,
      "relation": "partOf",
      "source": 22,
      "target": 4
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoformGradient": {
          "3R-High": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "In addition to the mainly cytoplasmic IR of RD4, RD3 IR extended into more distal dendrites  and neuropil threads. This extended RD3 IR was not explained by its higher sensitivity, because RD4 IR was more intense in the cytoplasm than in the dendrites, while this gradient was reversed with RD3 IR (red).",
      "key": "181ac7881239a6a8d2eb0af4f206591531055acf8b379cdd1bd3e51a7a691d9490e23468bb3ba68224acc9dc2c19049c27327e36a1c4b837dd5aa7db7c385696",
      "line": 344,
      "relation": "partOf",
      "source": 22,
      "target": 19
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoformGradient": {
          "3R-High": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "In addition to the mainly cytoplasmic IR of RD4, RD3 IR extended into more distal dendrites  and neuropil threads. This extended RD3 IR was not explained by its higher sensitivity, because RD4 IR was more intense in the cytoplasm than in the dendrites, while this gradient was reversed with RD3 IR (red).",
      "key": "53c55c4f2637527717f10cd1d7b8766415489140991b10ca0921a3403a6cac77889d5bcc78cb784b96a827cd53533704bcfbc1d1fb69abfa314524e2735c139c",
      "line": 345,
      "relation": "partOf",
      "source": 22,
      "target": 10
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoformGradient": {
          "3R-Low": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "In addition to the mainly cytoplasmic IR of RD4, RD3 IR extended into more distal dendrites  and neuropil threads. This extended RD3 IR was not explained by its higher sensitivity, because RD4 IR was more intense in the cytoplasm than in the dendrites, while this gradient was reversed with RD3 IR (red).",
      "key": "6349fbb9486ba496e26402f1545704599cc02a7344116e4fff4e0e9c68a2ef79f241e3bb81cf7caf3ce7214f36d2a3bfd1e29be92e4a4e56cd32f14f1d86e7eb",
      "line": 349,
      "relation": "partOf",
      "source": 22,
      "target": 18
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "Dendritic arborization was abundant in RD3-/4+ pretangles, attenuated in RD3+/4+ neurons, and further attenuated in RD3+/4- ghost tangles.",
      "key": "8160de6b88c2ef421ac7f55caac8b924d9990315403bc22f2cded425e172b4520f2b575bcaaeb7a25e5589a51d13e2877a3e1c0c1840b442850d200f1b5f4bcc",
      "line": 356,
      "relation": "increases",
      "source": 7,
      "target": 16
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "Dendritic arborization was abundant in RD3-/4+ pretangles, attenuated in RD3+/4+ neurons, and further attenuated in RD3+/4- ghost tangles.",
      "key": "edf571b8a612233557c54a8fddc5ee97839a7432e975f0fc4f2baa906dd8b4b177b712a756cd0e666bce8e2ed499cb5a94bdd1eebff50e89e76a0c5bbbcc119d",
      "line": 358,
      "relation": "decreases",
      "source": 6,
      "target": 16
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoformGradient": {
          "4R-Low": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "The RD3+/4- (red) fraction was consistently higher in EC and CA1, which was serially followed by CA2, CA3, and CA4. This trend was reversed with the RD3-/4+ (green) fraction, which was consistently highest in CA4, which was serially followed by CA3, CA2, CA1, and EC.",
      "key": "25fef0798df4f7845731a96c29edcf66765bffc6e1600474d89f56672ac4a75f3db33a1536eb94ce11e122f8c679d2b56dc3de2c88ddb79e122e93d438bf6fcb",
      "line": 337,
      "relation": "positiveCorrelation",
      "source": 0,
      "target": 23
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoformGradient": {
          "4R-Low": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "The RD3+/4- (red) fraction was consistently higher in EC and CA1, which was serially followed by CA2, CA3, and CA4. This trend was reversed with the RD3-/4+ (green) fraction, which was consistently highest in CA4, which was serially followed by CA3, CA2, CA1, and EC.",
      "key": "15adfab5b6d9c18b84e4588df0f12a416a1d3a0b90a17867d144713e74e0303ffcc7aec916e4fd5d92e039ff98c8e46a17486561a83a8a6d32e8d0479bc3b4fc",
      "line": 336,
      "relation": "positiveCorrelation",
      "source": 1,
      "target": 23
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoformGradient": {
          "4R-Medium": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "The RD3+/4- (red) fraction was consistently higher in EC and CA1, which was serially followed by CA2, CA3, and CA4. This trend was reversed with the RD3-/4+ (green) fraction, which was consistently highest in CA4, which was serially followed by CA3, CA2, CA1, and EC.",
      "key": "b5bed90673f348bb1252b43196de89f2e13f236923a0b8172a123510a54ad4208d9ad7f9de7bbcfedc13e569d82147bb75665ec71d2e17b04629cb10baeb8d8a",
      "line": 334,
      "relation": "positiveCorrelation",
      "source": 2,
      "target": 23
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoformGradient": {
          "4R-High": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "The RD3+/4- (red) fraction was consistently higher in EC and CA1, which was serially followed by CA2, CA3, and CA4. This trend was reversed with the RD3-/4+ (green) fraction, which was consistently highest in CA4, which was serially followed by CA3, CA2, CA1, and EC.",
      "key": "68c4a6be1b8c21ea1b29312d0d13a462b1d42c02e59a5e46af95057ede9e73a46c75ba7b07e81b336fada4d71c7c40d587c925db99c99c9dc00cbf9baa55ec61",
      "line": 332,
      "relation": "positiveCorrelation",
      "source": 3,
      "target": 23
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        },
        "TauIsoformGradient": {
          "4R-Very High": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "The RD3+/4- (red) fraction was consistently higher in EC and CA1, which was serially followed by CA2, CA3, and CA4. This trend was reversed with the RD3-/4+ (green) fraction, which was consistently highest in CA4, which was serially followed by CA3, CA2, CA1, and EC.",
      "key": "981cf970515fb72b2700309b9a32f38b557336bf47f0c484a8c786c7cd0c26f454e1dbb83dd970041a88dc3c964724cb5943cc26094dfdfc3dd225f207175de8",
      "line": 330,
      "relation": "positiveCorrelation",
      "source": 4,
      "target": 23
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "Dendritic arborization was abundant in RD3-/4+ pretangles, attenuated in RD3+/4+ neurons, and further attenuated in RD3+/4- ghost tangles.",
      "key": "ed3e70a7277cd131f9830977681345a46f98608461e7831fd626b667e04e299401b4c98b1219fc56c52fec1d969c9dea3123686d07186e8a196cb3a5f3386386",
      "line": 359,
      "relation": "positiveCorrelation",
      "source": 19,
      "subject": {
        "modifier": "Activity"
      },
      "target": 16
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage I": true,
          "Stage II": true,
          "Stage III": true,
          "Stage IV": true,
          "Stage V": true,
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Hara M",
          "Hirokawa K",
          "Kamei S",
          "Uchihara T"
        ],
        "date": "2013-04-01",
        "first": "Hara M",
        "last": "Uchihara T",
        "name": "Acta neuropathologica",
        "pages": "565-79",
        "reference": "23407988",
        "title": "Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.",
        "type": "PubMed",
        "volume": "125"
      },
      "evidence": "Dendritic arborization was abundant in RD3-/4+ pretangles, attenuated in RD3+/4+ neurons, and further attenuated in RD3+/4- ghost tangles.",
      "key": "8e7dcbfd37668635c136a08dc791bd9e6535306731009ec66ad12e068b5056ca75501328c8c5fa8e44b332d11e9083a19d1e12ada4204199bc93e44c35f323c1",
      "line": 359,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 16,
      "target": 19
    },
    {
      "annotations": {
        "Anatomy": {
          "basal nucleus of telencephalon": true
        },
        "Braak_Stage": {
          "Stage VI": true
        },
        "Cell": {
          "cholinergic neuron": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Laser Capture Microdissection": true,
          "Microarray": true,
          "RT-PCR": true,
          "Terminal Continuation RNA Amplification": true,
          "Western Blot": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Counts SE",
          "Coutadeur S",
          "Desire L",
          "Getova DP",
          "Geula C",
          "Ginsberg SD",
          "He B",
          "Mufson EJ",
          "Peillon H",
          "Perez SE"
        ],
        "date": "2012-02-01",
        "first": "Perez SE",
        "last": "Mufson EJ",
        "name": "The American journal of pathology",
        "pages": "526-40",
        "reference": "22142809",
        "title": "Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "180"
      },
      "evidence": "CBF tissues harvested from people who died with a clinical diagnosis of no cognitive impairment (NCI), mild cognitive impairment, or AD were immunolabeled for both p75NTR and Rac1b. Rac1b appeared as cytoplasmic diffuse granules, loosely aggregated filaments, or compact spheres in p75NTR-positive NB neurons. Although Rac1b colocalized with tau cytoskeletal markers, the percentage of p75NTR-immunoreactive neurons expressing Rac1b was significantly increased only in AD compared with both mild cognitive impairment and NCI.",
      "key": "757b93afd7f5d2fd010f97d0516418b6729558340b72ee9e8a3bd8e523bcb41696858db3eba70a586399805455669e3b8a13a71e531b39c3f57c503ca5b74bdd",
      "line": 377,
      "relation": "association",
      "source": 48,
      "target": 81
    },
    {
      "annotations": {
        "Anatomy": {
          "basal nucleus of telencephalon": true
        },
        "Braak_Stage": {
          "Stage VI": true
        },
        "Cell": {
          "cholinergic neuron": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Laser Capture Microdissection": true,
          "Microarray": true,
          "RT-PCR": true,
          "Terminal Continuation RNA Amplification": true,
          "Western Blot": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Counts SE",
          "Coutadeur S",
          "Desire L",
          "Getova DP",
          "Geula C",
          "Ginsberg SD",
          "He B",
          "Mufson EJ",
          "Peillon H",
          "Perez SE"
        ],
        "date": "2012-02-01",
        "first": "Perez SE",
        "last": "Mufson EJ",
        "name": "The American journal of pathology",
        "pages": "526-40",
        "reference": "22142809",
        "title": "Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "180"
      },
      "evidence": "CBF tissues harvested from people who died with a clinical diagnosis of no cognitive impairment (NCI), mild cognitive impairment, or AD were immunolabeled for both p75NTR and Rac1b. Rac1b appeared as cytoplasmic diffuse granules, loosely aggregated filaments, or compact spheres in p75NTR-positive NB neurons. Although Rac1b colocalized with tau cytoskeletal markers, the percentage of p75NTR-immunoreactive neurons expressing Rac1b was significantly increased only in AD compared with both mild cognitive impairment and NCI.",
      "key": "7e0836e807cd45383ffc39d7d16a0478a79e5829c2baa4d7080d1e31f409b07b184546dd21d9a4e2c8d7e053d0ab5705239c834383a479ef8c2fd68e86b45e3e",
      "line": 378,
      "relation": "isA",
      "source": 48,
      "target": 83
    },
    {
      "annotations": {
        "Anatomy": {
          "basal nucleus of telencephalon": true
        },
        "Braak_Stage": {
          "Stage VI": true
        },
        "Cell": {
          "cholinergic neuron": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Laser Capture Microdissection": true,
          "Microarray": true,
          "RT-PCR": true,
          "Terminal Continuation RNA Amplification": true,
          "Western Blot": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Counts SE",
          "Coutadeur S",
          "Desire L",
          "Getova DP",
          "Geula C",
          "Ginsberg SD",
          "He B",
          "Mufson EJ",
          "Peillon H",
          "Perez SE"
        ],
        "date": "2012-02-01",
        "first": "Perez SE",
        "last": "Mufson EJ",
        "name": "The American journal of pathology",
        "pages": "526-40",
        "reference": "22142809",
        "title": "Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "180"
      },
      "evidence": "Furthermore, single-cell gene expression profiling with custom-designed microarrays showed down-regulation of caveolin 2, GNB4, and lipase A in AD Rac1b-positive/p75NTR-labeled NB neurons compared with Rac1b-negative/p75NTRpositive perikarya in NCI. These proteins are involved in Rac1 pathway/cell cycle progression and lipid metabolism.",
      "key": "45e81e3214d38a758efe22cebb140b1b3921c654423b764595ea6a4a6108ae6f032403264aa8bf067d6d1343d8c4a90de06e92996638a40120fe8d3394f31a7f",
      "line": 386,
      "relation": "negativeCorrelation",
      "source": 48,
      "target": 59
    },
    {
      "annotations": {
        "Anatomy": {
          "basal nucleus of telencephalon": true
        },
        "Braak_Stage": {
          "Stage VI": true
        },
        "Cell": {
          "cholinergic neuron": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Laser Capture Microdissection": true,
          "Microarray": true,
          "RT-PCR": true,
          "Terminal Continuation RNA Amplification": true,
          "Western Blot": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Counts SE",
          "Coutadeur S",
          "Desire L",
          "Getova DP",
          "Geula C",
          "Ginsberg SD",
          "He B",
          "Mufson EJ",
          "Peillon H",
          "Perez SE"
        ],
        "date": "2012-02-01",
        "first": "Perez SE",
        "last": "Mufson EJ",
        "name": "The American journal of pathology",
        "pages": "526-40",
        "reference": "22142809",
        "title": "Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "180"
      },
      "evidence": "Furthermore, single-cell gene expression profiling with custom-designed microarrays showed down-regulation of caveolin 2, GNB4, and lipase A in AD Rac1b-positive/p75NTR-labeled NB neurons compared with Rac1b-negative/p75NTRpositive perikarya in NCI. These proteins are involved in Rac1 pathway/cell cycle progression and lipid metabolism.",
      "key": "56ee4ff53b6293be6caa05fab290b7d7847090e795f1dc1007afc4e58efae677c3a19d181db7857b9ded6f421cb7d06487e287aa6efeda680007232f6e9ec918",
      "line": 387,
      "relation": "negativeCorrelation",
      "source": 48,
      "target": 61
    },
    {
      "annotations": {
        "Anatomy": {
          "basal nucleus of telencephalon": true
        },
        "Braak_Stage": {
          "Stage VI": true
        },
        "Cell": {
          "cholinergic neuron": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Laser Capture Microdissection": true,
          "Microarray": true,
          "RT-PCR": true,
          "Terminal Continuation RNA Amplification": true,
          "Western Blot": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Counts SE",
          "Coutadeur S",
          "Desire L",
          "Getova DP",
          "Geula C",
          "Ginsberg SD",
          "He B",
          "Mufson EJ",
          "Peillon H",
          "Perez SE"
        ],
        "date": "2012-02-01",
        "first": "Perez SE",
        "last": "Mufson EJ",
        "name": "The American journal of pathology",
        "pages": "526-40",
        "reference": "22142809",
        "title": "Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "180"
      },
      "evidence": "Furthermore, single-cell gene expression profiling with custom-designed microarrays showed down-regulation of caveolin 2, GNB4, and lipase A in AD Rac1b-positive/p75NTR-labeled NB neurons compared with Rac1b-negative/p75NTRpositive perikarya in NCI. These proteins are involved in Rac1 pathway/cell cycle progression and lipid metabolism.",
      "key": "14906c3306bd721ca45a04ab2c3e1d46fbf7ba6d6321d45ffa9d5f5acf0c700d1dd659ecb47f0435fb16ad0eeb8035e891d7d784d3ff037af314b160d7937c2a",
      "line": 388,
      "relation": "negativeCorrelation",
      "source": 48,
      "target": 62
    },
    {
      "annotations": {
        "Anatomy": {
          "cerebral cortex": true
        },
        "Braak_Stage": {
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Laser Capture Microdissection": true,
          "Microarray": true,
          "RT-PCR": true,
          "Terminal Continuation RNA Amplification": true,
          "Western Blot": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Counts SE",
          "Coutadeur S",
          "Desire L",
          "Getova DP",
          "Geula C",
          "Ginsberg SD",
          "He B",
          "Mufson EJ",
          "Peillon H",
          "Perez SE"
        ],
        "date": "2012-02-01",
        "first": "Perez SE",
        "last": "Mufson EJ",
        "name": "The American journal of pathology",
        "pages": "526-40",
        "reference": "22142809",
        "title": "Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "180"
      },
      "evidence": "Because we also found Rac1b-positive neurons in the AD cortex, it will be interesting to determine whether these perikarya display a similar gene profile to that found in the NB cholinergic neurons.",
      "key": "7f15b8962ddd388120f81a68cc575179a1810b153f48fde6e93f418ffcb847bb9f4277074f8ddafa2e86533c00d25d00c11042a76e6066e75e7bd4a55de8c38d",
      "line": 396,
      "relation": "positiveCorrelation",
      "source": 48,
      "target": 5
    },
    {
      "annotations": {
        "Anatomy": {
          "basal nucleus of telencephalon": true
        },
        "Braak_Stage": {
          "Stage VI": true
        },
        "Cell": {
          "cholinergic neuron": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Laser Capture Microdissection": true,
          "Microarray": true,
          "RT-PCR": true,
          "Terminal Continuation RNA Amplification": true,
          "Western Blot": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Counts SE",
          "Coutadeur S",
          "Desire L",
          "Getova DP",
          "Geula C",
          "Ginsberg SD",
          "He B",
          "Mufson EJ",
          "Peillon H",
          "Perez SE"
        ],
        "date": "2012-02-01",
        "first": "Perez SE",
        "last": "Mufson EJ",
        "name": "The American journal of pathology",
        "pages": "526-40",
        "reference": "22142809",
        "title": "Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "180"
      },
      "evidence": "CBF tissues harvested from people who died with a clinical diagnosis of no cognitive impairment (NCI), mild cognitive impairment, or AD were immunolabeled for both p75NTR and Rac1b. Rac1b appeared as cytoplasmic diffuse granules, loosely aggregated filaments, or compact spheres in p75NTR-positive NB neurons. Although Rac1b colocalized with tau cytoskeletal markers, the percentage of p75NTR-immunoreactive neurons expressing Rac1b was significantly increased only in AD compared with both mild cognitive impairment and NCI.",
      "key": "96579dee843ecfeaa473ae1278e7ab7d276c590799af5c19234c4035f4797da5f1c29d8c63551e4526b7a3b4ac26a4bb08430b7a6b3f9e12217eaf45c4307b80",
      "line": 377,
      "relation": "association",
      "source": 81,
      "target": 48
    },
    {
      "annotations": {
        "Anatomy": {
          "basal nucleus of telencephalon": true
        },
        "Braak_Stage": {
          "Stage VI": true
        },
        "Cell": {
          "cholinergic neuron": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Laser Capture Microdissection": true,
          "Microarray": true,
          "RT-PCR": true,
          "Terminal Continuation RNA Amplification": true,
          "Western Blot": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Counts SE",
          "Coutadeur S",
          "Desire L",
          "Getova DP",
          "Geula C",
          "Ginsberg SD",
          "He B",
          "Mufson EJ",
          "Peillon H",
          "Perez SE"
        ],
        "date": "2012-02-01",
        "first": "Perez SE",
        "last": "Mufson EJ",
        "name": "The American journal of pathology",
        "pages": "526-40",
        "reference": "22142809",
        "title": "Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "180"
      },
      "evidence": "Furthermore, single-cell gene expression profiling with custom-designed microarrays showed down-regulation of caveolin 2, GNB4, and lipase A in AD Rac1b-positive/p75NTR-labeled NB neurons compared with Rac1b-negative/p75NTRpositive perikarya in NCI. These proteins are involved in Rac1 pathway/cell cycle progression and lipid metabolism.",
      "key": "41e03eddef35cb97e7e33cc4c91409859f88026f7616474b80d25d5bf8740fe55d408125ec3136a462f766ee19016d9a9d9d1956107465227589ce420ccceab8",
      "line": 386,
      "relation": "negativeCorrelation",
      "source": 59,
      "target": 48
    },
    {
      "annotations": {
        "Anatomy": {
          "basal nucleus of telencephalon": true
        },
        "Braak_Stage": {
          "Stage VI": true
        },
        "Cell": {
          "cholinergic neuron": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Laser Capture Microdissection": true,
          "Microarray": true,
          "RT-PCR": true,
          "Terminal Continuation RNA Amplification": true,
          "Western Blot": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Counts SE",
          "Coutadeur S",
          "Desire L",
          "Getova DP",
          "Geula C",
          "Ginsberg SD",
          "He B",
          "Mufson EJ",
          "Peillon H",
          "Perez SE"
        ],
        "date": "2012-02-01",
        "first": "Perez SE",
        "last": "Mufson EJ",
        "name": "The American journal of pathology",
        "pages": "526-40",
        "reference": "22142809",
        "title": "Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "180"
      },
      "evidence": "Furthermore, single-cell gene expression profiling with custom-designed microarrays showed down-regulation of caveolin 2, GNB4, and lipase A in AD Rac1b-positive/p75NTR-labeled NB neurons compared with Rac1b-negative/p75NTRpositive perikarya in NCI. These proteins are involved in Rac1 pathway/cell cycle progression and lipid metabolism.",
      "key": "55d3e24bb00c19fea861fb5f93490a417baa397ae6391b9d56a2de0129df0f76750812320425b237475d1e4d6e9de56acb0f05fac0a29e52d731eb1861d76754",
      "line": 387,
      "relation": "negativeCorrelation",
      "source": 61,
      "target": 48
    },
    {
      "annotations": {
        "Anatomy": {
          "basal nucleus of telencephalon": true
        },
        "Braak_Stage": {
          "Stage VI": true
        },
        "Cell": {
          "cholinergic neuron": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Laser Capture Microdissection": true,
          "Microarray": true,
          "RT-PCR": true,
          "Terminal Continuation RNA Amplification": true,
          "Western Blot": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Counts SE",
          "Coutadeur S",
          "Desire L",
          "Getova DP",
          "Geula C",
          "Ginsberg SD",
          "He B",
          "Mufson EJ",
          "Peillon H",
          "Perez SE"
        ],
        "date": "2012-02-01",
        "first": "Perez SE",
        "last": "Mufson EJ",
        "name": "The American journal of pathology",
        "pages": "526-40",
        "reference": "22142809",
        "title": "Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "180"
      },
      "evidence": "Furthermore, single-cell gene expression profiling with custom-designed microarrays showed down-regulation of caveolin 2, GNB4, and lipase A in AD Rac1b-positive/p75NTR-labeled NB neurons compared with Rac1b-negative/p75NTRpositive perikarya in NCI. These proteins are involved in Rac1 pathway/cell cycle progression and lipid metabolism.",
      "key": "c997841923df98b03309cad6415974bdf80b044c973f6f3583e8656075009ca2d4f4ee4d797a40eaa5ce028ca7266f39a13a88de962f474cd7bdae7964db9f80",
      "line": 388,
      "relation": "negativeCorrelation",
      "source": 62,
      "target": 48
    },
    {
      "annotations": {
        "Anatomy": {
          "cerebral cortex": true
        },
        "Braak_Stage": {
          "Stage VI": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Method": {
          "Immunohistochemistry": true,
          "Laser Capture Microdissection": true,
          "Microarray": true,
          "RT-PCR": true,
          "Terminal Continuation RNA Amplification": true,
          "Western Blot": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Counts SE",
          "Coutadeur S",
          "Desire L",
          "Getova DP",
          "Geula C",
          "Ginsberg SD",
          "He B",
          "Mufson EJ",
          "Peillon H",
          "Perez SE"
        ],
        "date": "2012-02-01",
        "first": "Perez SE",
        "last": "Mufson EJ",
        "name": "The American journal of pathology",
        "pages": "526-40",
        "reference": "22142809",
        "title": "Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "180"
      },
      "evidence": "Because we also found Rac1b-positive neurons in the AD cortex, it will be interesting to determine whether these perikarya display a similar gene profile to that found in the NB cholinergic neurons.",
      "key": "8a9aa09bd0f98ba167994d9bd0131b555f301a173cd2c2d0a4c7a1f3efa69740a93f0351410aeb577dd049ce598f9ad540884813dc80f776a859350bbe27fb83",
      "line": 396,
      "relation": "positiveCorrelation",
      "source": 5,
      "target": 48
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CONSO:\"Brodmann (1909) area 36\")",
      "function": "Abundance",
      "id": "d362d2bb02bcb2f4ad3f2d6d66d0087cb5a7a273381708c5b67f230f0b532938d0191c1c367e27148abfd82e40f4815916ba5d63e1cd80decd3e9bf76592d087",
      "name": "Brodmann (1909) area 36",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:\"CA1 field of hippocampus\")",
      "function": "Abundance",
      "id": "a9f69a8ba06a4c0877f0229245ffa9d68edf744026b465b4b2692fc115a7abd062d94984cbf46f4638addc9db58ae3b1cec371132b5d716a710e5086b4fd9073",
      "name": "CA1 field of hippocampus",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:\"CA2 field of hippocampus\")",
      "function": "Abundance",
      "id": "2c2f6debfee267804585849c852b3acbdcca36f8e6ce25ae7619723fff30dd4f47173c1c72042a3dc56c1f439850ab2bbd246f26c9b9640bfa7794f861ee3810",
      "name": "CA2 field of hippocampus",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:\"CA3 field of hippocampus\")",
      "function": "Abundance",
      "id": "fca2988ae0fb0d87bc2d3264b45b71ac7e9aaded467f5fcefb0ba8b8a977e4fd3c1264cc872bcec55f6f72916101580824fef8ef44c562d2ba6b8c52efcf9e27",
      "name": "CA3 field of hippocampus",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:\"CA4 field of hippocampus\")",
      "function": "Abundance",
      "id": "2b8f59758ecf1ca2d017d30d347aabddce3839850f741376424f644944583433c047c8af2bbe1c651b03cefbb31702749204ded213c64c4731850b3d2699ba90",
      "name": "CA4 field of hippocampus",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:\"cerebral cortex\")",
      "function": "Abundance",
      "id": "8d2a5e3d626e90e46c9a961b96e0493019bff42cc376e35d16fe243033e16f2b39fc7161e90882ef2eec5b961b6d1d4d50d0f3343119c69c34ca4479ec16dcc1",
      "name": "cerebral cortex",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:\"ghost tangles\")",
      "function": "Abundance",
      "id": "86eafa11b7d9a04ab9f6aa3a91b5a36150660bffb1ae07beb3eb9d5c76ff7bbc1444df60a75b002c2e67be4ca6168227e1547837dca4e91ff633ce2f223915ce",
      "name": "ghost tangles",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:pretangles)",
      "function": "Abundance",
      "id": "66706e3c91d294d3a7ca363c2b5cb1188a3a5c62bef261a3239b6692b554be687d306339b5a77830eeb36c6e2ee87a75799a5f23cdc23c3f0ff24793c9e1b018",
      "name": "pretangles",
      "namespace": "CONSO"
    },
    {
      "bel": "a(MESH:Brain)",
      "function": "Abundance",
      "id": "9175288a6c7b6ef9b1d5b27898a9df1220476f7b15df878df555ca1003f86131d9293d04e396275cf70eb020d39ca118c7325524f243d1b6cdd28f86130be6f8",
      "name": "Brain",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Neurons)",
      "function": "Abundance",
      "id": "130131072f276d163b9e361a4ca4814f1d254907d297db502ccb4f6e75dff10db1f2b384bb435c9b46e91310d585aea1db3108e00905a31bb1388ccda1f0c643",
      "name": "Neurons",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Neuropil)",
      "function": "Abundance",
      "id": "186bc996a6a13f0bd5e8d61d989d4079eb2419c4b94a149532586d89d72001d642ebbe54b051ea1da13df175eab4f7ee96d4413e1d903e14a92baf9fef2e68a9",
      "name": "Neuropil",
      "namespace": "MESH"
    },
    {
      "bel": "bp(GO:\"clathrin-dependent endocytosis\")",
      "function": "BiologicalProcess",
      "id": "7639b43ef23b19d79d11020dab549264613ef3e5db7a2daf76d40b01e5234260732f8668affc59b84fc039419743e8e7ae81d1d7b66f55b4c1f43c261aae425e",
      "name": "clathrin-dependent endocytosis",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"neurofibrillary tangle assembly\")",
      "function": "BiologicalProcess",
      "id": "ddb806442eeaf16c4573d02545b21939cd739066593dc5fde6d82f5d5b7bad5b274420d38fb8d36b39d6ab68d6de55b663d56fca339fd516217d141e702e5815",
      "name": "neurofibrillary tangle assembly",
      "namespace": "GO"
    },
    {
      "bel": "bp(MESH:Mitosis)",
      "function": "BiologicalProcess",
      "id": "de110ec7edef1d9337ca58f73bb8a1c9c35117595f597e27b1a58d8bd3d93f35f26a760f3bdb49c3106ee542458ec2b8d1064aedeb1d7322034edb6e62763fd8",
      "name": "Mitosis",
      "namespace": "MESH"
    },
    {
      "bel": "complex(GO:\"Cajal body\")",
      "function": "Complex",
      "id": "c080a187f662c99df4fdfacde67daea96a018634140d335b5841558b541ae1e4d9d293de7e1a26e3a90611f05118ded969c51ca97c76d720354fa7bc85bec09c",
      "name": "Cajal body",
      "namespace": "GO"
    },
    {
      "bel": "complex(GO:\"Pick body\")",
      "function": "Complex",
      "id": "9c5d3ca57357e60048354eaffd134a2872126b0004b4d1a78b1f7ab20d3d2b1d73445c6a3d4cdc9c6f0dcb0925e7cf91abddff7902c498b7b5bd450f089c78be",
      "name": "Pick body",
      "namespace": "GO"
    },
    {
      "bel": "complex(GO:\"dendritic tree\")",
      "function": "Complex",
      "id": "af7682b85e9a0a5833e20324c3d4f1a223448426e41b219f010893fa3a85520169b5afb0313629482668f66b6a8f7748d24f59bdf2fb0ee140008cb0627ab1dc",
      "name": "dendritic tree",
      "namespace": "GO"
    },
    {
      "bel": "complex(GO:\"neurofibrillary tangle\")",
      "function": "Complex",
      "id": "83563b0bf7b4e8223bab3bc7bfc5d3f34eef173b06c17dc9313fe7f786eebd3eda569f012c7293bdcece2a95a9c825fee6f7643ff2c31525f6806be2449fbdcb",
      "name": "neurofibrillary tangle",
      "namespace": "GO"
    },
    {
      "bel": "complex(GO:\"neuronal cell body\")",
      "function": "Complex",
      "id": "46e345a3743c2d13237916581f766139a90d2261232ea415bf46123998b853461566d177bd95d1550254cd5233ba646c0e7d5dbde56d6a108b7a6999f1296d97",
      "name": "neuronal cell body",
      "namespace": "GO"
    },
    {
      "bel": "complex(GO:dendrite)",
      "function": "Complex",
      "id": "1cf735e3599d57c81d04920a7efb40a15abfe585301e9f3b1b975f769c322b1dd0b87b5986435da7c07c876e2acbfe35138493ab0eaf74823e3f2e07dc9b0a5a",
      "name": "dendrite",
      "namespace": "GO"
    },
    {
      "bel": "complex(p(CONSO:\"AP-2 complex\"), p(HGNCGENEFAMILY:\"Clathrin subunits\"))",
      "function": "Complex",
      "id": "ee96aa89ce35391b5a51e23bb91bb590f82fcc430878fd5c45b2fa8811cc3ab0bd99efec1c752cd8e4a92260bc753d9696f460e9edfa9b69384affcc21c11077",
      "members": [
        {
          "bel": "p(CONSO:\"AP-2 complex\")",
          "function": "Protein",
          "id": "7dc0eeb64429f821ee71790d511bbafde0ff4c1634b22b477f1cbc8af98a3e6416e670c170f5e00b58c7d9c35adab4c2c4ee07b60abcb87749ecdab55a8e712d",
          "name": "AP-2 complex",
          "namespace": "CONSO"
        },
        {
          "bel": "p(HGNCGENEFAMILY:\"Clathrin subunits\")",
          "function": "Protein",
          "id": "717ed31e96de950c1d153b77f6e596bb79d2de1c798242647571a921576d6e279944707fc6e5498b04ec5a18aa6709b84ea08cbb708e8a1e8fe2f9cefb0f1d27",
          "name": "Clathrin subunits",
          "namespace": "HGNCGENEFAMILY"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:MAPT), p(HGNCGENEFAMILY:Tubulins))",
      "function": "Complex",
      "id": "7720634adb53551c988b660b0db9cb73945e42743f07ba913a87074d8d5964b81eaaf78f465056f80c57bbc5c66b42137d18a412db8ed2ad25a2bb86ebd9b2e2",
      "members": [
        {
          "bel": "p(HGNC:MAPT)",
          "function": "Protein",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1",
          "name": "MAPT",
          "namespace": "HGNC"
        },
        {
          "bel": "p(HGNCGENEFAMILY:Tubulins)",
          "function": "Protein",
          "id": "324eb02c65169e7a583a43ee128ed844b5c108fc4d0a4ae7ad0d5cc6db3c3da60b70719f5de9b87efc1f0e09bb8d753028201d1f815f971a39d6fa306086dce7",
          "name": "Tubulins",
          "namespace": "HGNCGENEFAMILY"
        }
      ]
    },
    {
      "bel": "p(CONSO:\"3R tau\")",
      "function": "Protein",
      "id": "e7bbe0c9b202ab819b9e86058d2eeaddd2a44b718b0efbd55a3556b330a91777b75e5a5c55b928cbfa13493f72bdd68e2c082dda8f4127f5f2246788973e77ac",
      "name": "3R tau",
      "namespace": "CONSO"
    },
    {
      "bel": "p(CONSO:\"4R tau\")",
      "function": "Protein",
      "id": "3b22a9cfd225f94deb93dbfa42139095d7890c19ebc65973c257a2594c5554a74d058de9ba5d2c251b3fc8a7fd6b2562983962ad41011fb53aa2e574452cf372",
      "name": "4R tau",
      "namespace": "CONSO"
    },
    {
      "bel": "p(CONSO:\"AP-2 complex\")",
      "function": "Protein",
      "id": "7dc0eeb64429f821ee71790d511bbafde0ff4c1634b22b477f1cbc8af98a3e6416e670c170f5e00b58c7d9c35adab4c2c4ee07b60abcb87749ecdab55a8e712d",
      "name": "AP-2 complex",
      "namespace": "CONSO"
    },
    {
      "bel": "p(CONSO:\"Tau isoform B (381 aa)\")",
      "function": "Protein",
      "id": "e20fe5a9032317cca866485d715679a634d1d8f234cd3a1d30b761389be0c99ac2a2005e7e2a4d23265350e9180c8a21e55c29d1a425c81600af0e25074c5936",
      "name": "Tau isoform B (381 aa)",
      "namespace": "CONSO"
    },
    {
      "bel": "p(CONSO:\"Tau isoform C (410 aa)\")",
      "function": "Protein",
      "id": "0a1d75d1b74ea13dbd738370489b7a1e586a7fb931d063cff7ec87ae5965d9f675cac26cf6a3a60f05ba83ec94a5758688b12b71aed8c3162abf5c9597a2b655",
      "name": "Tau isoform C (410 aa)",
      "namespace": "CONSO"
    },
    {
      "bel": "p(CONSO:\"Tau isoform D (383 aa)\")",
      "function": "Protein",
      "id": "e50f4f2ea51daa7590ebd133d002b1e7dbb4cbae2cd53ef99d28bef65111fa69ea24fa6c649894944f18a1c318d92329e75b5a147da9e1697deac1329eeca65a",
      "name": "Tau isoform D (383 aa)",
      "namespace": "CONSO"
    },
    {
      "bel": "p(CONSO:\"Tau isoform E (412 aa)\")",
      "function": "Protein",
      "id": "3646a58387b7eb24164448e877dc758fe63825fc36c530dede26977282ac21d118a286ad29e653bfe98d8d14fce6bc0812dc8a49c3bf81baa64a73fb02b7f410",
      "name": "Tau isoform E (412 aa)",
      "namespace": "CONSO"
    },
    {
      "bel": "p(CONSO:\"Tau isoform F (441 aa)\")",
      "function": "Protein",
      "id": "00367ae0b38226280c90b32288fd8cc4ecc717167adaf7bee9c0a1afbb03387cafb6392a4e3f7b533e88d728f63336cc06559af4651793e7b8fac417375e5274",
      "name": "Tau isoform F (441 aa)",
      "namespace": "CONSO"
    },
    {
      "bel": "p(CONSO:\"Tau isoform F (441 aa)\", frag(\"244_274\"))",
      "function": "Protein",
      "id": "4d23c76cedda083f70129d45fdc4dd528c6eb04af76dd2fb1e115b346908f65b889d71d769c6920c46451ed2fa303f01967163761f1316c85f41d644162e46cb",
      "name": "Tau isoform F (441 aa)",
      "namespace": "CONSO",
      "variants": [
        {
          "kind": "frag",
          "start": 244,
          "stop": 274
        }
      ]
    },
    {
      "bel": "p(CONSO:\"Tau isoform F (441 aa)\", frag(\"275_305\"))",
      "function": "Protein",
      "id": "977c80978127a9054fdcb085e3908f4dfec7afc07be9efa971ba0de96ba7d810dc4819309893587b8e614694369b714cac14bcd6a962aa99d1febf66e7880e9d",
      "name": "Tau isoform F (441 aa)",
      "namespace": "CONSO",
      "variants": [
        {
          "kind": "frag",
          "start": 275,
          "stop": 305
        }
      ]
    },
    {
      "bel": "p(CONSO:\"Tau isoform F (441 aa)\", frag(\"306_336\"))",
      "function": "Protein",
      "id": "8b16d0c1e5af05dbe0cd3a080b8456e1b23264f13640296ffb3c32db45713d88ffa5293d237e0584e9e87a1f14dce78a9cf1e2dfb5cb9983d4c594e35a3839cf",
      "name": "Tau isoform F (441 aa)",
      "namespace": "CONSO",
      "variants": [
        {
          "kind": "frag",
          "start": 306,
          "stop": 336
        }
      ]
    },
    {
      "bel": "p(CONSO:\"Tau isoform F (441 aa)\", frag(\"337_367\"))",
      "function": "Protein",
      "id": "0ccc682960ced21be53ace8a817feb804760a24ca3020d81210d663f1a4b3bcbc20a97afe27eca08029e0bf0b84821a944a1bcf2c4c27e9319e61094990e7193",
      "name": "Tau isoform F (441 aa)",
      "namespace": "CONSO",
      "variants": [
        {
          "kind": "frag",
          "start": 337,
          "stop": 367
        }
      ]
    },
    {
      "bel": "p(CONSO:\"Tau isoform F (441 aa)\", var(\"p.Pro301Leu\"))",
      "function": "Protein",
      "id": "51db343bb87623bae823da6b30f1fd44d95fb2da9daef82c14d8210b4a8a1ff00cb33c67af0c6f514f85df52a0a4fe98a6526a3d6574e2820a5865dc791e1b6d",
      "name": "Tau isoform F (441 aa)",
      "namespace": "CONSO",
      "variants": [
        {
          "identifier": "p.Pro301Leu",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(CONSO:\"Tau isoform Fetal-tau (352 aa)\")",
      "function": "Protein",
      "id": "02f44a5b89856ea29a0659ed2589c3a41bad6931869de183281186b80cf7a3d2b9c9e9ca917299b2a99a1e294258831eb798c032093a49b670f0391bc73c94e9",
      "name": "Tau isoform Fetal-tau (352 aa)",
      "namespace": "CONSO"
    },
    {
      "bel": "p(CONSO:\"VQIINK motif\")",
      "function": "Protein",
      "id": "81dd386db372beaa0992acc45d5348691731a0bafa393ed1572a491e0e6c3593cc76c0618cd174a0a64e0f58d19eda468ec11d6857d66ffe5792451290af6d2b",
      "name": "VQIINK motif",
      "namespace": "CONSO"
    },
    {
      "bel": "p(CONSO:\"VQIVYK motif\")",
      "function": "Protein",
      "id": "687e6d78c01965f7457a9da85a087fd59213b9a1914c689b4054a3cc6e36a9a20ae68d2adadf04b925fcd5fc77cc9fe4a92f3c3515a276723328019437f70c3e",
      "name": "VQIVYK motif",
      "namespace": "CONSO"
    },
    {
      "bel": "p(CONSO:\"assembly domain\")",
      "function": "Protein",
      "id": "27e225594be2400e55d717d766cbfefc2e32a9211dc64d74374401e575c475b831c9337c1b99ba6df0155544aedd0470fef76c1865f7dbe4f98c5340beb04bb5",
      "name": "assembly domain",
      "namespace": "CONSO"
    },
    {
      "bel": "p(CONSO:\"microtubule-binding region\")",
      "function": "Protein",
      "id": "1b34f9d3e5ae9fe22a2a3503388afe991bdeb55115a5f57a860ca924755597616729c7d3d863230c6d9571cd7ba29040fb471db4ba2d119ed0e493936a590da2",
      "name": "microtubule-binding region",
      "namespace": "CONSO"
    },
    {
      "bel": "p(CONSO:\"projection domain\")",
      "function": "Protein",
      "id": "69309c35659932eacf6d3e53863b5104add511501db20608e32355af949140e6b63d528d0a584754b60a8b0c1373867972dc7e10f714c1ffb12a2831e77d4fad",
      "name": "projection domain",
      "namespace": "CONSO"
    },
    {
      "bel": "p(CONSO:\"proline-rich domain\")",
      "function": "Protein",
      "id": "b712af7393f2101009ed19338b4bf63a981db908846e01dc2280aa264f230dde74cc6e8d7a692aee47f7273c6a8edab7aec378be3cc823a422fb81746bc0518e",
      "name": "proline-rich domain",
      "namespace": "CONSO"
    },
    {
      "bel": "p(CONSO:\"proline-rich region 1\")",
      "function": "Protein",
      "id": "8c19cb2f77f523fa8df4c84a8b566bbbc1fb1ff744850f6602a76ce914df644414213181ff2675b612be988f2e6ec89a91ea28358380b25690d31adefcead062",
      "name": "proline-rich region 1",
      "namespace": "CONSO"
    },
    {
      "bel": "p(CONSO:\"proline-rich region 2\")",
      "function": "Protein",
      "id": "c0611d49f22e38da92ae6717c8887f9440b96513807d57cc6f13b3f906d12d4e5c5dd397bef635c0df8a333ee77aafe76627afe68383eb8b23c2982b2a7eb4d3",
      "name": "proline-rich region 2",
      "namespace": "CONSO"
    },
    {
      "bel": "p(CONSO:\"tubulin-binding repeat 1\")",
      "function": "Protein",
      "id": "afbd4c5259a5977266e8c392cbd458d118ad1c210774f09c4a61fdb8c7a551300327f5246f42e0ff7844f55c32d6967a045cf4ba33bfbd2041832815419b26f8",
      "name": "tubulin-binding repeat 1",
      "namespace": "CONSO"
    },
    {
      "bel": "p(CONSO:\"tubulin-binding repeat 2\")",
      "function": "Protein",
      "id": "7a1a7d0f3c89a33f23cfba6f6360a3312c84504fe5f7b2a500cd6ce8c35a0d4e46ea18d51d243f96f61282b8b7f9c1872e05560760f54e098195437efa55e352",
      "name": "tubulin-binding repeat 2",
      "namespace": "CONSO"
    },
    {
      "bel": "p(CONSO:\"tubulin-binding repeat 3\")",
      "function": "Protein",
      "id": "0b21d5cc893497b0bfa7142e82badef3787aef7c8a7d313ed19f932c6c495e2098786feb17547802a9a9d3113692c5f20f854a6d752fde7f137b4150186b936f",
      "name": "tubulin-binding repeat 3",
      "namespace": "CONSO"
    },
    {
      "bel": "p(CONSO:\"tubulin-binding repeat 4\")",
      "function": "Protein",
      "id": "f67914cec94a2c40773679547d4952a3bb1c08bd139b147cae1a414683aae69f6a664e9ac8070413d71b80ea5a1728205247b50258ee21de2d9c6bb76ff2319c",
      "name": "tubulin-binding repeat 4",
      "namespace": "CONSO"
    },
    {
      "bel": "p(CONSO:RAC1b)",
      "function": "Protein",
      "id": "3decaa9604990a9388262ccd682f40565e1e61fc8d0e388dc9fd9e38addf4f98a5864300b9bd42b2156e308f31c120741e57fdf6548c995b7f99c3f2a68f76e7",
      "name": "RAC1b",
      "namespace": "CONSO"
    },
    {
      "bel": "p(FPLX:PKA)",
      "function": "Protein",
      "id": "a312e28f30d661eb58c0cc3c07cda6812a6290acaa1b8c513be7a895fe1b15f1feb278ee6095359cd3e44eb43cf1864de0fd70d89d3cbcc5b18361fd31276f17",
      "name": "PKA",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:PKC)",
      "function": "Protein",
      "id": "12137fadfdc5eb838cd33edabcf36ac0b775609d7303971d52755e1335928a559973fe26211ce3ac9a8599ee75c77a978b44d1d7114437a922a8911d9016aceb",
      "name": "PKC",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:PRKG)",
      "function": "Protein",
      "id": "7278f3fd90c62f7c42ae1d699e21c1d498129b53432ae5295f7f3c84bcf3389ea7f4fb3d3bc931d0b023eea3407691afc9150d41aafa27e914c9bc4d7e5e7a2e",
      "name": "PRKG",
      "namespace": "FPLX"
    },
    {
      "bel": "p(HGNC:ABL1)",
      "function": "Protein",
      "id": "d2c9c266b57718f71c9b5ea0da0e48ba77dbe172cbc7dc550631f8c9a9540767992c47b332bd0760ed1959c3b0e4a073a3f52d2cdc4985f132d91eb43e6ca027",
      "name": "ABL1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:AP2A1)",
      "function": "Protein",
      "id": "5caf7e8b61381f5c2b3be6de29059c028181cd1aced0483a246bb2a17ea756d0a09f76fc09d7d40ac7f55908e6e25c4a82701f8810b5cdef9d141598d2e2119b",
      "name": "AP2A1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:AP2A2)",
      "function": "Protein",
      "id": "5f134209528fe8b11593efd244ffff182b3ed27d955241d5cedb8a30eedf2915aec7de92831b37b4f45ee43e2a63b76585151375d215ce830eeae5ff34cc2b64",
      "name": "AP2A2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:AP2B1)",
      "function": "Protein",
      "id": "f598bd580780ea4a0be2eb9334e61dd8e61bb844ccd7c8db8dda3f58d35527a74f588bd75c65e96658c58183a2246b17b221f0d93930a43897b5ebaedf2bf51a",
      "name": "AP2B1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:AP2M1)",
      "function": "Protein",
      "id": "20eaaa5160abe945cca0ee84bb4b3c090db1c6fd40c8837aa77af1296db2e0611cbef605c132720826fe56abf007a40c2a4fc452b43d036a7803ac3759a6e954",
      "name": "AP2M1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:AP2S1)",
      "function": "Protein",
      "id": "581ef2c9cea4f8d66c51867ff634ccfd113f09ba94f105e5e65209e7f69eeb67c520fb88edeb6acccec7f79b256a7a520b4a7b6139f3c577606dc8ce1ecb7614",
      "name": "AP2S1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:BECN1)",
      "function": "Protein",
      "id": "ce5e6cfc287bf6d0e84facb5b47e9a27acc7790b28ca4e133b28be3d5e182582aeb37e2a9ed8c867ec8bebff972f5132a6ef26bfd08dbf95abd402d24504486d",
      "name": "BECN1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CAV2)",
      "function": "Protein",
      "id": "fceebe145983a347dc6ec8107b4fa6df7b1c1b29074ce17188c221a1568ca379f597801facaae4c8d95593446b990cd977317db5b92de99068d9f2d6b09befbe",
      "name": "CAV2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:FYN)",
      "function": "Protein",
      "id": "ecffd0427f2e321c9ed5143ca2510464c2fef5432457c332ee991bda79dbdd12ace6375208ee66760cc5b9b7990248651b41a370f16eb9459d2b8682cb0da86b",
      "name": "FYN",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:GNB4)",
      "function": "Protein",
      "id": "aba0877c6d49588e88d8679ecdd1dc0d135b78e75f7233e50d81023492f632bf8a5d10cbd7e9976f5a59be1c04aa6fcced551668bdb15dffc5fd8093aa43bf21",
      "name": "GNB4",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:LIPA)",
      "function": "Protein",
      "id": "48e086b605480d52a5eb102010f3590d53d772ca0538295dc7e591a2470040155c07eb7d2acbd6ca783942295d81bca3cab7860b8f88c3c084f035895eeb93ee",
      "name": "LIPA",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:MAP1LC3B)",
      "function": "Protein",
      "id": "6eea9648838dcae7c4eea2331bffcc8b554691fcedb483616344719d109e84504c88266a3c40e8cf021fb230d4aa574204d0c206491fe9809009fa9026a4b44a",
      "name": "MAP1LC3B",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:MAPT)",
      "function": "Protein",
      "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1",
      "name": "MAPT",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:MAPT, frag(\"151_198\"))",
      "function": "Protein",
      "id": "39bc6c481d605b93413e57f0a573baae335022f1de5417cb4b719dd048774e191accbcf3a04206ff13c6c8d07c21d3e408893b25ed96544990e15392fd1c44d1",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "kind": "frag",
          "start": 151,
          "stop": 198
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, frag(\"199_244\"))",
      "function": "Protein",
      "id": "17e6943c6fb5f50e15b7f88823e5de477164134eb9592f69c0a7d9499801853fd78e3fa6428fde17f896ea3cf044b358830d4f48c00dd45f2a219fdee367f33c",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "kind": "frag",
          "start": 199,
          "stop": 244
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, frag(\"199_370\"))",
      "function": "Protein",
      "id": "6d3d03e32a4fc68ae386d13148d5bb099d8ad2ed148649b0a04ab9f8cba991222c5e948c37d4f0876aa1bec03694114e4da8ca24be70b4e5c2d09aa802e13acc",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "kind": "frag",
          "start": 199,
          "stop": 370
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, frag(\"199_441\"))",
      "function": "Protein",
      "id": "c33fef38b28de95635499c7b3019e5d3b1404860091b6f70c2b67f6bbdf80b3e6be2d0f43a424120ef7ab4faea6f4f9e97b316728e8a679ada0239660d8a7f7a",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "kind": "frag",
          "start": 199,
          "stop": 441
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, frag(\"1_151\"))",
      "function": "Protein",
      "id": "860a16fdbb3f05127020770dec43578bf30abef211907ecbce2be6e20cd39562564a2baa20b13344faa0ce7b4c2884492e1299c19c1cde6e6ad23457b79a1852",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "kind": "frag",
          "start": 1,
          "stop": 151
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, frag(\"1_198\"))",
      "function": "Protein",
      "id": "9f58b87c1027cd995f7d404abfa9514af920063d245dc3d0e442ea8e3eee59bf4181cba36e13542180154791eac9d76e5c86190b304bd1ef6acc0ccf83014305",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "kind": "frag",
          "start": 1,
          "stop": 198
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, frag(\"244_369\"))",
      "function": "Protein",
      "id": "27b196a92b4344f0c0391f2ba088acc02c935784a93d442bf2c898b7d98c7574355aa67b4081fb940d08f28d9037b31795d993c2fbfeada1e10d017e78dd42bf",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "kind": "frag",
          "start": 244,
          "stop": 369
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, frag(\"370_441\"))",
      "function": "Protein",
      "id": "f0d93f3065e4b2169ac6951ce1304a5f7ed3e20980a3758d75f8750ef6b0e1ceff7cc1d5dfd54a563366a6291e477d200c9f9d9de62f7b70f55605d7d27a71fe",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "kind": "frag",
          "start": 370,
          "stop": 441
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph))",
      "function": "Protein",
      "id": "526bae251987f8c4f55f6e2451662fa55e087c57585beae7c389b020d73487c739834e9b8ec841783de6a5b5fb9df8b138e9eff4406a9ec5e606766575dcac0e",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 214))",
      "function": "Protein",
      "id": "46b14deb2ecfa74d6446d3e6b46a5346cb195bfb1f14bf84cda1781071705183d0e3122edc843b7716047c6050b9fa1b4c05319f6cdd0e15964d1e33098ed086",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 214
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 262))",
      "function": "Protein",
      "id": "c20d653a77090fa48337a73d9915475bcb411eb52f7e239d287da66a8d92ac32ac84146976f90af86f112ccd6fb631b1dea88f465bf333cf545de4f9a44d07ef",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 262
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 293))",
      "function": "Protein",
      "id": "1b5143cde2b7897fa7a020b145e0a9fce4f2df640ac4ba9366d12105516cb8ead50636fce3f63a0c44b71f830b7a031eed8b5609566e66097b303ad88e7f528f",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 293
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 324))",
      "function": "Protein",
      "id": "4805a0edf03796a5683c509e11a5b33bdc67387a40e06b23089c93257a13c3bc4533e83c5c74391ed15159cd6b8fa3deded29418730b0eaaca178c5870b9e44d",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 324
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 356))",
      "function": "Protein",
      "id": "48317023adebba2bdbc3547d0f7ee43578ecb436211b91ef867ec4d820c385520ab83ed151305262f74205eb47f03ee242509a03e3210e94a0ea5a87589d4241",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 356
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Tyr, 18))",
      "function": "Protein",
      "id": "5b045c071b780caaf6d0a4441b95389b9857364de91d6676af9d7497e2f4fd2ceda3e2ac4bb7f5e526690284a133fa5fce968527f72d8e1582029f1551a0c7bc",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "code": "Tyr",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 18
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Tyr, 394))",
      "function": "Protein",
      "id": "a6049a3fe7e4c819ff2c683d6a0b4603e380eb1a924cba6add2bf64e44f0d3bdc913d0ba77528062ad380e45e0f41a83069b70e52b528e119678559c79c89b4d",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "code": "Tyr",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 394
        }
      ]
    },
    {
      "bel": "p(HGNC:NGFR)",
      "function": "Protein",
      "id": "cd78700c9feba4b7aed402f9d26d83106682ce3f4d3e862f85d599795b156db4845164e76939ebc527639b83487714396dec6e2a2acf6b0fb6283ef3be7fc6fa",
      "name": "NGFR",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:PICALM)",
      "function": "Protein",
      "id": "1baf71acaa1a0777092dead04c4827cd5e184984ae77050f14b6ac758a7947e13e5f30bc2d9d5b4abff5ca71ea6f8284279e4edb12c870ab4fbb7deaadbdedb2",
      "name": "PICALM",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:RAC1)",
      "function": "Protein",
      "id": "1fb022c2de2f8912cb3e05798b6e9f44f07e6bb387d9a93fd99151de2bb49ca2494576b2ce2935975991c9bb4d53372c2fad23454a01e170f139bbc85eb7aecc",
      "name": "RAC1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Clathrin subunits\")",
      "function": "Protein",
      "id": "717ed31e96de950c1d153b77f6e596bb79d2de1c798242647571a921576d6e279944707fc6e5498b04ec5a18aa6709b84ea08cbb708e8a1e8fe2f9cefb0f1d27",
      "name": "Clathrin subunits",
      "namespace": "HGNCGENEFAMILY"
    },
    {
      "bel": "p(HGNCGENEFAMILY:Tubulins)",
      "function": "Protein",
      "id": "324eb02c65169e7a583a43ee128ed844b5c108fc4d0a4ae7ad0d5cc6db3c3da60b70719f5de9b87efc1f0e09bb8d753028201d1f815f971a39d6fa306086dce7",
      "name": "Tubulins",
      "namespace": "HGNCGENEFAMILY"
    },
    {
      "bel": "p(INTERPRO:\"MAP2/Tau projection\")",
      "function": "Protein",
      "id": "115223264f85ca3aef98a34b4f7fa26c291ada3889afbf815fa89cac6eccb6045720e2d1a7005edc6b0d7221ad0328f6bfce6f3bf6116903608028012a53f49d",
      "name": "MAP2/Tau projection",
      "namespace": "INTERPRO"
    },
    {
      "bel": "p(INTERPRO:\"Microtubule associated protein,  tubulin-binding repeat\")",
      "function": "Protein",
      "id": "ffe6c2520919a074aef36363573933e7eb43bdfbd1c01709f572bd8a5a24e614688d50198bf7c6fca64b7957338d401516e127a8468468aeaeadc5be3720afd3",
      "name": "Microtubule associated protein,  tubulin-binding repeat",
      "namespace": "INTERPRO"
    },
    {
      "bel": "p(INTERPRO:\"Microtubule associated protein,  tubulin-binding repeat\", pmod(Ph))",
      "function": "Protein",
      "id": "f8a57b8cc94e2c7576e21b7d45f01606c73c5ca0b4fd601f532125e67b469d5d149151456269a90227dc91089476d47e5eeaa9708019cba1f826b83840ec6718",
      "name": "Microtubule associated protein,  tubulin-binding repeat",
      "namespace": "INTERPRO",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(INTERPRO:\"PSP, proline-rich\")",
      "function": "Protein",
      "id": "cf8e9ed40e61594b568a43eca045cb6510015bcc77b1d1f895cfd5028eeb99a0466a75fa474d0071cdcced01a3a778a3a96f1a3fde00b657dfc26a1d90fe34b5",
      "name": "PSP, proline-rich",
      "namespace": "INTERPRO"
    },
    {
      "bel": "path(CONSO:\"granulovacuolar degeneration\")",
      "function": "Pathology",
      "id": "d239c346d2ed0af13b4841b01fecec57be2d6ee631687b9ea0ed3c886c0389c5bf0756bdaab539ce592e761fe0eee0af511fa062c76bc1b0d3d07bcea25a626f",
      "name": "granulovacuolar degeneration",
      "namespace": "CONSO"
    },
    {
      "bel": "path(MESH:\"Alzheimer Disease\")",
      "function": "Pathology",
      "id": "00f72839b5d655cb4cb088b0eb8874bd406284d98a2afd0bdd73de0a34adb78af374b0eb26990387f41d3b41cda0e32c1b5ff5f86ed63d0fdc841bac17865541",
      "name": "Alzheimer Disease",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Frontotemporal Dementia\")",
      "function": "Pathology",
      "id": "65b349369f9bedd1a6220b3923747475397a886cb45f96f65e9aad66d695cfd560911459bd006d087e0ee4cbf06d8829549b3e32854fe68093e2b5834049d726",
      "name": "Frontotemporal Dementia",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Pick Disease of the Brain\")",
      "function": "Pathology",
      "id": "7917fa738d79ac0c2819622046fe373e477ef318b8693a75fd3871cd7df292afac3f425f2393f72cbb2813ca81347b925f64a4b874ca7d64c778c9d6e189eead",
      "name": "Pick Disease of the Brain",
      "namespace": "MESH"
    }
  ]
}